{"text": "The median follow - up was 2.3 ( range , 1.1 - 4.6 ) years for the surviving patients .Locoregional recurrence .At the time of analysis , 9 local recurrences and 9 regional recurrences were observed in 12 patients .", "label": "", "metadata": {}, "score": "36.63894"}
{"text": "In their studies of patients treated with BCT with 15 year data,[27,28 ] patients developed both true recurrences and new primaries at similar rates until approximately 8 years , when true recurrence rates stabilized but new primary rates continued to rise .", "label": "", "metadata": {}, "score": "37.231606"}
{"text": "2010 Mar 6;375(9717):816 - 23 . )Median F / U 3.75 years .Outcome : 5-year vaginal recurrence VBT 1.8 % vs EBRT 1.6 % ( NS ) ; 5-year loco - regional relapse 5.1 % vs 2.1 % ( NS ) ; isolated pelvic recurrence 1.5 % vs 0.5 % ( NS ) ; DM 8.3 % vs 5.7 % ( NS ) .", "label": "", "metadata": {}, "score": "38.032425"}
{"text": "Moreover , an additional PET / CT correctly identified six false - negative cases as recurrences which were interpreted as benign or equivocal by ceCT .", "label": "", "metadata": {}, "score": "38.53129"}
{"text": "Seven patients had recurrences requiring retreatment ( 30 % ) .Clinical outcome ( average , 32.9 months ) was good in 75 % of patients and poor in 25 % .", "label": "", "metadata": {}, "score": "38.833534"}
{"text": "Results .Among the 50 patients , 34(68 % ) were confirmed to have a recurrence .PET / CT showed higher sensitivity ( 88 % vs .", "label": "", "metadata": {}, "score": "39.444504"}
{"text": "Median time to recurrence 1.7 years .Median F / U 2.7 years .Outcome : no LR recurrence , 1 patient DM ; 5-year LC 100 % , DFS 96 % , DSS 96 % .", "label": "", "metadata": {}, "score": "39.451263"}
{"text": "First of all , the majority of recurrent cases were confirmed clinically .Our standard for non - recurrence required no significant changes in the lesion for a minimum of 3 months ; however , such a criterion has not been validated and may be insufficient for confirmation .", "label": "", "metadata": {}, "score": "39.729485"}
{"text": "One patient ( 3 % ) had fatal rebleeding 18 days after treatment .Overall , procedure - related morbidity and mortality were , respectively , 3 % and 6 % .", "label": "", "metadata": {}, "score": "40.049038"}
{"text": "Outcome : vaginal recurrence PXRT 5 versus VCB / C 2 ; pelvic recurrence 2 vs 19 ; distant failure 32 vs 24 .RFS 82 % vs 84 % ( NS ) ; OS 93 % vs 92 % ( NS ) .", "label": "", "metadata": {}, "score": "40.309654"}
{"text": "Of these six false - negative cases by ceCT , three were first interpreted as post - operative inflammatory changes .For the other three cases , lymph node metastasis was not confidently interpreted as a recurrence due to the insignificant size .", "label": "", "metadata": {}, "score": "41.393448"}
{"text": "The median follow - up time was 49.1 months ( range 5.1 - 86 , standard error 11.5 ) .Before 18 F - FDG PET / CT was undertaken , there had been suspicious CT lesions for recurrence in 30 patients .", "label": "", "metadata": {}, "score": "41.72361"}
{"text": "[ 4 ] .Several retrospective as well as prospective studies evaluating patterns of local relapse following BCS with or without radiation have shown that the majority of tumor recurrences occurred at or near the original tumor bed .", "label": "", "metadata": {}, "score": "41.73523"}
{"text": "In addition , recurrences in other areas were categorized as metastases .When evaluating findings of 18 F - FDG PET / CT on ceCT as recurrences , at least one image finding of recurrence was necessary .", "label": "", "metadata": {}, "score": "41.835808"}
{"text": "Detection of Recurrence by 18 F - FDG PET / CT and ceCT .The median interval between ceCT and 18 F - FDG PET / CT was 17 days ( range , 1 - 70 days ) .", "label": "", "metadata": {}, "score": "41.87157"}
{"text": "Overall survival .Eleven patients ( 21 % ) died during follow - up ; 9 due to cancer progression ( cancer specific deaths ) , one patient due to cachexia and the other due to cardiac failure .", "label": "", "metadata": {}, "score": "42.176514"}
{"text": "Among the 50 patients , 34 had confirmed recurrences .Only 6 patients were eligible for pathologic confirmation ( 5 by biopsy , 1 by surgery ) : 4 lesions were recurred malignancies and 1 lesion was benign .", "label": "", "metadata": {}, "score": "42.4245"}
{"text": "No pts received VB .Median f / u 69.5 months .5-yr DFS 86.7 % , OS 97.6 % .No pt had a local / vaginal recurrence .", "label": "", "metadata": {}, "score": "42.725323"}
{"text": "Similar recurrence rate in both groups , but more deaths in XRT group .Subset analysis : Improved OS for BT+EBRT in IC Grade 3 ( 82 % vs. 72 % ) ; probably due to improved local control ( LR 5 % vs. 20 % ) with comparable DM ( 14 % vs. 15 % ) .", "label": "", "metadata": {}, "score": "42.90033"}
{"text": "Relapse - free survival was 64 % at 5 years and 52 % at 8 years .The incidence of grade 3 - 5 complications was 13 % at 5 years and 15 % in 8 years .", "label": "", "metadata": {}, "score": "43.090496"}
{"text": "Eight patients , 5 of which had both a flap reconstruction and extracapsular extension ( ECE ) , showed an unusual multifocal pattern of recurrence .", "label": "", "metadata": {}, "score": "43.345596"}
{"text": "2009 Jan 10;373(9658):137 - 46 .Epub 2008 Dec 16 . )Median F / U 4.8 years .Outcome : 5-year OS OBS 84 % vs EBRT 84 % ( NS ) , DSS 90 % vs 89 % ( NS ) , Recurrence 15 % vs. 15 % , Isolated vaginal or pelvic recurrence OBS 6 % vs. EBRT 3 % ( SS ) .", "label": "", "metadata": {}, "score": "43.468723"}
{"text": "We therefore propose to describe recurrences as unifocal or multifocal as this is an important predictor for surgical salvage [ 19 ] .Eight out of our 12 recurrences had extensive surgery requiring flap reconstruction , and 5 of these failed multifocally involving the flap reconstruction .", "label": "", "metadata": {}, "score": "44.500946"}
{"text": "10-year LR : invasive 13 % vs. 8 % ( SS ) , 42 % reduction ; DCIS 14 % vs. 7 % ( SS ) , 48 % reduction .", "label": "", "metadata": {}, "score": "45.163063"}
{"text": "4 recurrences : 2 LR and 2 DM .All patients with recurrence did not have chemo .Toxicity : 1 treatment - related death from adjuvant chemo ; 2 late carotid pseudoaneurysms with torrential epistaxis .", "label": "", "metadata": {}, "score": "45.197258"}
{"text": "Outcome : 10-year LR boost 13 % vs no boost 12 % ( NS ) ; 10-year invasive LR 6 % vs 7 % ( NS ) ; DCIS 5 % vs 7 % ( NS ) .", "label": "", "metadata": {}, "score": "45.239025"}
{"text": "Looking at all tumors , this was 80 % and 73 % , respectively .There were 11 local recurrences with a median time of 34 months , with two late recurrences , one at 77 months another at 79 months .", "label": "", "metadata": {}, "score": "45.511223"}
{"text": "Outcome : 4-year recurrence conventional 6 % vs hypo - fx 6.7 % ( NS ) .High grade increased risk of LR ( 11 % for Gr3 vs 4 % for Gr 1/2 , SS ) .", "label": "", "metadata": {}, "score": "45.561005"}
{"text": "Gynecol Oncol .2004 Mar;92(3):744 - 51 . )Median F / U 5.7 years .Outcome : 2-year recurrence rate : 3 % vs 12 % ( SS ) .", "label": "", "metadata": {}, "score": "45.819916"}
{"text": "Conclusion : 11 % of DCIS patients had invasive disease ; use of SLND allowed them to avoid axillary dissection .Considered rare until 1980 's , prior to advent of population - wide mammographic screening .", "label": "", "metadata": {}, "score": "45.89057"}
{"text": "2001 Dec 1;51(5):1246 - 55 . )Median F / U 5 years .Late complications : RT 26 % vs. control 4 % ( SS ) .", "label": "", "metadata": {}, "score": "45.989754"}
{"text": "Recurrence 64 % less if negative SM vs positive SM ( OR 0.4 , SS , using trial definition of negative margin , which ranged from no cells at ink to 10 mm ) .", "label": "", "metadata": {}, "score": "46.011635"}
{"text": "However , these results do not reach statistical significance , probably due to the low number of patients .On the other hand , an additional 18 F - FDG PET / CT on ceCT significantly improves the sensitivity in detecting recurrences .", "label": "", "metadata": {}, "score": "46.40821"}
{"text": "18S ( June 20 Supplement ) , 2007 : 5504 ) .Median F / U 3.8 years .5-year outcome : OS 84 % both groups ( NS ) , DSS 89 % ( NS ) ; small difference in isolated vaginal / pelvic recurrence with brachytherapy .", "label": "", "metadata": {}, "score": "46.45851"}
{"text": "Secondary endpoints included distant metastasis - free survival ( DMFS ) , overall survival ( OS ) , acute and late toxicities .Results .Overall 53 patients were analyzed .", "label": "", "metadata": {}, "score": "46.707375"}
{"text": "( Susumu N , Gynecol Oncol .2007 Nov 8) .Median F / U .Outcome : 5-year PFS 83 % vs 82 % ( NS ) ; OS 85 % vs. 87 % ( NS ) .", "label": "", "metadata": {}, "score": "47.05468"}
{"text": "4-year OS 92 % vs 86 % ( NS ) .In HIR subgroup ( 34 % ) : 2-yr recurrence , 6 % vs 26 % .", "label": "", "metadata": {}, "score": "47.122833"}
{"text": "Six of the total 12 locoregional recurrences occurred within the CTV54 ; 10 of the 12 marginally or outside of the CTV60 - 66 or CTV72 ( Table 3 ) .", "label": "", "metadata": {}, "score": "47.135925"}
{"text": "A similar pattern of failure is reported by Yao et al .[ 8 ] with 4 out of 9 locoregional failures being multifocal and 3 of these 4 failing in both CTV60 and CTV64 - 66 , though neither aspect is discussed in the paper .", "label": "", "metadata": {}, "score": "47.342903"}
{"text": "Median F / U 2.4 years .Outcome : 2-year DFS chemo - RT 68 % vs. RT alone 72 % ( NS ) ; OS 80 % vs. 80 % ( NS ) ; no difference in LRC , DM , or time - to - relapse .", "label": "", "metadata": {}, "score": "47.37847"}
{"text": "( Rakovitch E , J Clin Oncol .2007 Dec 10;25(35):5591 - 6 .Epub 2007 Nov 5 . )Retrospective .Outcome : local recurrence BCS alone 21 % ( 50 % invasive ) vs. BCS+RT 9 % ( 24 % invasive ) ; 10-year LRFR BCS alone 72 % vs. BCS+RT 82 % .", "label": "", "metadata": {}, "score": "47.816887"}
{"text": "Retrospective .16 patients with NPC .Initial treatment 50 - 88 Gy ( 1 postop RT 50 Gy , 16 primary 65 - 88 Gy ) .", "label": "", "metadata": {}, "score": "47.95597"}
{"text": "2005 Mar 15;61(4):1054 - 61 . )12-year rates : invasive 18 % vs. 8 % , noninvasive 16 % vs. 9 % .", "label": "", "metadata": {}, "score": "47.96753"}
{"text": "These patients could potentially be treated with BCS alone . \"High risk \" patients - while RT does offer significant benefit , the rate of recurrence is still unacceptably high .", "label": "", "metadata": {}, "score": "48.187393"}
{"text": "Terminated due to slow accrual .372 patients .Initially , surgical Stage I ; later ammended to include occult II , IIIA ( positive peritoneal fluid only ) , or IIIC ( positive LNs only ) with high risk features .", "label": "", "metadata": {}, "score": "48.9438"}
{"text": "Two patients received 72 Gy as there was evidence of macroscopic neck metastasis during treatment planning .The median number of chemotherapy cycles was 3 ( range , 2 - 3 ) .", "label": "", "metadata": {}, "score": "49.05706"}
{"text": "For the confirmation of recurrence by ceCT , the RECIST criteria were used [ 14 ] .When a postoperative image finding was uneventful : no locoregional recurrence and no distant metastasis , we can define a benign finding .", "label": "", "metadata": {}, "score": "49.074333"}
{"text": "Two other board - certified radiologists , who were blinded to the diagnosis , independently interpreted ceCT images for the recurrence .All lesions on the ceCT were interpreted as recurrent , equivocal , or benign .", "label": "", "metadata": {}, "score": "49.301357"}
{"text": "71 % patients received all 3 cycles of concurrent chemo .3-years ; 2005 PMID 16170180 -- \" Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer / International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety . \"", "label": "", "metadata": {}, "score": "49.405216"}
{"text": "1998 Feb;16(2):441 - 52 . )F / U 7.5 years . 8-year IBTR : invasive 13.4 % vs. 3.9 % ( SS ) , noninvasive 13.4 % vs. 8.2 % ( SS ) .", "label": "", "metadata": {}, "score": "49.51548"}
{"text": "Patient and treatment characteristics .In total 53 patients were retrospectively analyzed .Prior to treatment , a PET - CT scan was used on 9 patients ( 17 % ) .", "label": "", "metadata": {}, "score": "49.745407"}
{"text": "Unsuspected invasive cancer in 11 % ; of these , 20 % had SLN+ .However , overall SLN+ in 11 % ( micromets 1 % , ITCs 10 % ) , suggesting 10 % SLN+ ( 94 % ITCs ) in patients with DCIS only .", "label": "", "metadata": {}, "score": "49.83925"}
{"text": "( Chua DT , Cancer .1998 Dec 1;83(11):2270 - 83 . )Median F / U 2.5 years .Outcome : 3-year RFS induction chemo 48 % vs. RT 42 % ( NS ) ; OS 78 % vs. 71 % ( NS ) .", "label": "", "metadata": {}, "score": "49.876358"}
{"text": "The median time to locoregional recurrence was not reached .The 2- and 3-year LRRFS estimates were both 79 % ( Figure 1A ) .", "label": "", "metadata": {}, "score": "50.069183"}
{"text": "229 NPC patients , T1N1-T4N3 .Complete remission after RT , then Arm 1 ) observation vs. Arm 2 ) VCA ( vincristine , cyclophosphamide , adriamycin ) x 6 monthly cycles .", "label": "", "metadata": {}, "score": "50.176003"}
{"text": "1990 Aug;8(8):1342 - 51 . )Subset analysis , 27 NPC patients , 96 % Stage IV , 67 % poorly differentiated .Median F / U 1.5 years .", "label": "", "metadata": {}, "score": "50.62733"}
{"text": "( Kwong DL , J Clin Oncol .2004 Jul 1;22(13):2643 - 53 . ) 3-year adjuvant chemo vs. none FFS 62 % vs. 65 % ( NS ) , OS 80 % vs. 83 % ( NS ) , no difference on LRC or DM .", "label": "", "metadata": {}, "score": "50.63447"}
{"text": "( Kwong DL , J Clin Oncol .2004 Jul 1;22(13):2643 - 53 . ) 3-year adjuvant chemo vs. none FFS 62 % vs. 65 % ( NS ) , OS 80 % vs. 83 % ( NS ) , no difference on LRC or DM .", "label": "", "metadata": {}, "score": "50.63447"}
{"text": "Local recurrences occurred in 7/14 of the locally recurrent vs. 4/36 primary tumor .Local recurrences occurred in 5/29 chordomas vs. 5/14 chondrosarcomas and only 1 primary chordoma had a local recurrence .", "label": "", "metadata": {}, "score": "50.72153"}
{"text": "We consecutively enrolled 50 patients with BTC who underwent curative surgery .An 18 F - FDG PET / CT was obtained for assessment of recurrence based on clinical suspicion during post - operative surveillance .", "label": "", "metadata": {}, "score": "50.795143"}
{"text": "From this information , five patients could receive palliative chemotherapy , whereas the other patient could not receive chemotherapy because of poor performance status .Moreover , an additional PET / CT showed no 18 F - FDG uptake in five false - positive cases by ceCT , which provided decisive information to the clinicians .", "label": "", "metadata": {}, "score": "50.82579"}
{"text": "2010 Jun;95(3):317 - 20 .Epub 2010 Apr 17 . )Retrospective .266 patients , conventional 50/25 ( 39 % ) or hypofractionated 42.4/16 or 40/16 + 12.5 Gy boost ( 61 % ) WBRT after BCS for DCIS .", "label": "", "metadata": {}, "score": "50.956844"}
{"text": "5-year outcome : OS : IB - C G1 - 2 83 - 85 % , IB G3 74 % , IC G3 58 % ; DM rate 3 - 8 % , 20 % , and 31 % .", "label": "", "metadata": {}, "score": "50.98552"}
{"text": "Meta - analysis .Individual patient data for 4 randomized trials .3729 women .10-year data .Women with small , low - grade tumors and negative SM still benefited ( 30 % vs 12 % , SS ) .", "label": "", "metadata": {}, "score": "51.042217"}
{"text": "Approximately 50 % of patients in observation arm received vaginal brachytherapy .There was no OS or DFS benefit , and higher toxicity .Due to low number of events , none of the trials were really powered to show overall survival benefit .", "label": "", "metadata": {}, "score": "51.089622"}
{"text": "Retrospective .11 patients .Recurrent NPC , with base of skull invasion , CN deficit 64 % .Heavy charged particles .Initial treatment median 70.2 Gy ( 61 - 81 Gy ) .", "label": "", "metadata": {}, "score": "51.13414"}
{"text": "For VNPI scores of 5 - 7 , there was a 17 % decrease ( 85 % vs 68 % ) in RFS when RT was used .", "label": "", "metadata": {}, "score": "51.166718"}
{"text": "Figure 2 presents a flow diagram showing the identification of recurrences based on imaging findings .For 14 lesions with discordant results , 18 F - FDG PET / CT was 79 % identical to the final recurrence status ( 11 of 14 ) .", "label": "", "metadata": {}, "score": "51.260063"}
{"text": "2010 Apr;251(4):583 - 91 . )Retrospective .194 patients , DCIS , excision alone or excision + RT .Outcome : IBTR 10-year 22 % , 15-years 29 % .", "label": "", "metadata": {}, "score": "51.447304"}
{"text": "Median F / U 7.4 years .Outcome : On re - excision , 56 % residual DCIS and 6 % residual IDC . 7-year LRF if re - excision 9.6 % vs RT + boost 9.3 % ( NS ) .", "label": "", "metadata": {}, "score": "51.47242"}
{"text": "Retrospective .223 patients , DCIS treated with skin - sparing mastectomy and immediate reconstruction .No adjuvant RT .Mean F / U 6.9 years .", "label": "", "metadata": {}, "score": "51.718407"}
{"text": "The study by Kim et al enrolled 123 patients with suspected and potentially operable cholangiocarcinomas , and demonstrated that PET / CT showed no advantage over ceCT in the diagnosis of primary tumors , but was more valuable in the diagnosis of regional lymph node and distant metastases [ 11 ] .", "label": "", "metadata": {}, "score": "51.822567"}
{"text": "Multifocality : 10-year LRFR multifocal 59 % vs. unifocal 80 % ( SS ) ; but if treated with BCS+RT , no difference ( 80 % vs. 87 % , NS ) .", "label": "", "metadata": {}, "score": "51.901894"}
{"text": "Late grade 3 complications included : 2 sacral neuropathies , 1 erectile dysfunction , 1 stress fracture , 1 secondary sarcoma , 1 rectal bleed .", "label": "", "metadata": {}, "score": "52.2285"}
{"text": "Additionally , because of the high risk of recurrence , it is recommended that surveillance includes radiologic evaluation with an abdominal CT scan every 6 months for 2 - 3 years [ 3 , 4 ] .", "label": "", "metadata": {}, "score": "52.27658"}
{"text": "J Clin Oncol .1998 Apr;16(4):1310 - 7 .Median F / U 2.7 years .3-year outcome : PFS chemo - RT 69 % vs. RT alone 24 % ( SS ) ; OS 78 % vs 47 % ( SS ) .", "label": "", "metadata": {}, "score": "52.379818"}
{"text": "18S ( June 20 Supplement ) , 2007 : 5503 ) .Median F / U 3.5 years .Outcome : PFS RT alone 75 % vs. RT+CT 82 % ( SS ) .", "label": "", "metadata": {}, "score": "52.434547"}
{"text": "Thus , 18 F - FDG PET was merely confirmatory because recurrences were also identified on conventional imaging .Unlike the aforementioned studies , the current analysis documented the complementary role of 18 F - FDG PET / CT under a frequently encountered situation in the clinic in which clinicians suspected a recurrence .", "label": "", "metadata": {}, "score": "52.47297"}
{"text": "2003 Feb 15;21(4):631 - 7 . )Median F / U 5.4 years .5-year outcome : PFS RT alone 53 % vs. chemo - RT 72 % ( SS ) ; OS 54 % vs. 72 % ( SS ) .", "label": "", "metadata": {}, "score": "52.538414"}
{"text": "There are also cases in which no definite recurrent lesions are detected on ceCT following measurement of elevated tumor markers , such as CA19 - 9 or CEA , with or without suspicious symptoms .", "label": "", "metadata": {}, "score": "52.591614"}
{"text": "Outcome : locoregional recurrence 3.4 % ( 1 vaginal recurrence , 1 pelvic recurrence , and 1 vagina+pelvis recurrence ) .Conclusion : VB alone reasonable for high risk localized endometrial CA .", "label": "", "metadata": {}, "score": "52.609184"}
{"text": "Randomized .392 patients , treated with TAH / BSO , selective PLN and PALND .Originally included \" intermediate risk \" -- stages IB , IC , and II ( occult ) , any grade , with negative LN .", "label": "", "metadata": {}, "score": "52.64286"}
{"text": "( Nout RA , Clin Oncol 26 : 2008 ( May 20 suppl ; abstr LBA5503 ) )Median F / U 2.8 years .Outcome : 3-year vaginal relapse EBRT 2.0 % vs. VBT 0.9 % ( NS ) , pelvic relapse 0.7 % vs. 3.6 % ( SS ) , OS 90 % vs. 91 % ( NS ) .", "label": "", "metadata": {}, "score": "52.67966"}
{"text": "Randomized .Trial stopped early due to significant survival benefit .147 patients .NPC Stage III - IV ( Stage IV 91 % ; but also included few N1 patients , which are IIB today ) , histology WHO I ( 25 % ) , WHO II ( 35 % ) , WHO III ( 41 % ) .", "label": "", "metadata": {}, "score": "52.83541"}
{"text": "LR rate : 15 % , LR - free survival at 10 years : No RT 46 % vs. 72 % RT no boost vs. 86 % RT boost ( SS ) .", "label": "", "metadata": {}, "score": "52.874947"}
{"text": "42 % underwent lymph node dissection .17 % had RT : 9.4 % WPRT alone , 4.6 % VB alone , and a combination in 3.7 % .", "label": "", "metadata": {}, "score": "52.96008"}
{"text": "All planning PTVs were treated sequentially in a \" shrinking - volume \" technique with a fractionation of 5 times 2 Gy per week , resulting in two or three treatment plans per patient .", "label": "", "metadata": {}, "score": "53.054695"}
{"text": "2010 Jun 25 .[ Epub ahead of print ] ) .Registry trial .194 patients , DCIS , MammoSite registry .Placement at lumpectomy 45 % , post - lumpectomy 55 % .", "label": "", "metadata": {}, "score": "53.11087"}
{"text": "34 patients concurrent cisplatin ( initial 11 were RT only to establish safety , subsequent patients offered INT 0099 protocol ) .Median F / U 2.1 years .", "label": "", "metadata": {}, "score": "53.128944"}
{"text": "Analysis of recurrences .The relation of all recurrences to both CTVs was assessed sequentially .Statistical considerations .The primary endpoint was locoregional recurrence - free survival ( LRRFS ) .", "label": "", "metadata": {}, "score": "53.132774"}
{"text": "( Fisher B , N Engl J Med .1993 Jun 3;328(22):1581 - 6 . )Mean f / u 3.6 years .5-year EFS : 74 % vs. 84 % ( SS ) .", "label": "", "metadata": {}, "score": "53.292686"}
{"text": "2001 Aug;28(4):400 - 18 . )Update on B-17 and B-24 .F / U 12 years .10-year IBTR : 30.8 % vs. 14.9 % ( 57 % reduction ) ; Invasive 16.4 % to 7.1 % ( 62 % reduction ) .", "label": "", "metadata": {}, "score": "53.30802"}
{"text": "N Engl J Med . 1999 May 13;340(19):1455 - 61 .Retrospective .469 pts .Pts treated until 1989 received post - op RT and those treated after 1989 did not .", "label": "", "metadata": {}, "score": "53.44873"}
{"text": "Grade 3 37 % .Median F / U 4.5 years .Outcome : IBTR 3.1 % , breast / axilla recurrence 0.5 % , 5-year local recurrence 3.4 % .", "label": "", "metadata": {}, "score": "53.478073"}
{"text": "Outcome : 4-year OS 86 % ( 3 % dead due to endometrial CA , 10 % dead due to other causes ) .", "label": "", "metadata": {}, "score": "53.797237"}
{"text": "( Chan AT , J Clin Oncol .2002 Apr 15;20(8):2038 - 44 . )Median F / U 2.7 years .Outcome : 2-year PFS chemo - RT 76 % vs. RT alone 69 % ( NS ) .", "label": "", "metadata": {}, "score": "53.822266"}
{"text": "Then randomized to no further treatment vs pelvic RT 40 Gy ( central shielding after 20 Gy ) .9-years , 1980 ( 1968 - 1974 ) - PMID 6999399 - \" Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma : clinical and histopathologic study of 540 patients . \"", "label": "", "metadata": {}, "score": "53.897026"}
{"text": "Swedish DCIS Trial ( 1987 - 1999 ) -- RT vs No RT .Randomized . 1046 women , DCIS on sector resection , target clinical surgical margin 1 cm but microscopically negative SM not required ; clinically N0 .", "label": "", "metadata": {}, "score": "54.078484"}
{"text": "2006 Sep 1;66(1):142 - 51 . )Median F / U 2.9 years .Outcome : 3-year FFS RT 70 % , AFRT 63 % , chemo - RT 74 % , chemo - AFRT 94 % ( SS ) .", "label": "", "metadata": {}, "score": "54.257694"}
{"text": "949 pts with DCIS , 604 excision alone , 345 excision + RT .No hormonal therapy .Used the updated USC / Van Nuys scoring system ( size , margin , DCIS classification , age ) which gives scores 4 - 12 .", "label": "", "metadata": {}, "score": "54.353256"}
{"text": "2006 Aug 7;95(3):266 - 71 .Epub 2006 Jul 25 . )Median F / U 8.0 years .Outcome : 5-year OS RT 69 % vs. chemo 66 % ( NS ) ; 5-year PFS 63 % vs. 63 % ( NS ) .", "label": "", "metadata": {}, "score": "54.36464"}
{"text": "This study is to determine the clinical role of 18 F - FDG PET / CT during post - operative surveillance of suspected recurrent BTC based on symptoms , laboratory findings and contrast - enhanced CT ( ceCT ) findings .", "label": "", "metadata": {}, "score": "54.3787"}
{"text": "( Petignat P , Gynecol Oncol .2006 Jun;101(3):445 - 9 . )Retrospective .22 patients with endometrial CA , isolated vaginal recurrence .82 % EBRT + HDR , 18 % HDR only .", "label": "", "metadata": {}, "score": "54.465282"}
{"text": "In 39 recurrent lesions ( multiples included ) , 16 were recurrent near the locoregional area and 16 were recurrent in the lymph nodes ( Table 3 ) .", "label": "", "metadata": {}, "score": "54.82739"}
{"text": "DM unaffected ( 7 % ) .Salvage : Most LR salvaged , which may explain why the survival is similar in both arms despite a difference in LR . 3-year OS after vaginal relapse 69 % vs. 13 % for pelvic or DM .", "label": "", "metadata": {}, "score": "54.870987"}
{"text": "( Chi KH , Int J Radiat Oncol Biol Phys .2002 Apr 1;52(5):1238 - 44 . )Median F / U 4.1 years .Outcome : 5-year OS RT alone 60 % vs. adjuvant chemo 50 % ( NS ) , RFS 54 % vs. 54 % ( NS ) .", "label": "", "metadata": {}, "score": "54.887474"}
{"text": "Interestingly , 19 of 28 patients of adjuvant treatment group ( 67.9 % ) were recurred .Median time interval between ceCT and 18 F - FDG PET / CT was 17 days ( range 1 - 70 ) and 17 patients had the longer interval than 3 weeks .", "label": "", "metadata": {}, "score": "54.91539"}
{"text": "LRRFS after postoperative IMRT is satisfying and toxicity is acceptable .The majority of locoregional recurrences occurred marginally or outside of the high - risk target volumes .", "label": "", "metadata": {}, "score": "55.04072"}
{"text": "2005 Oct 1;23(28):6966 - 75 . )Median F / U 2.3 years .Outcome : DFS chemo - RT 72 % vs. RT alone 62 % ( SS ) , LRC 92 % vs. 82 % ( SS ) , DM 76 % vs. 73 % ( NS ) , OS 78 % vs. 78 % ( NS ) .", "label": "", "metadata": {}, "score": "55.126495"}
{"text": "Survival after vaginal relapse 73 % , after pelvic relapse 8 % , after DM relapse 14 % .Vaginal salvage : 5-year OS : control group better 65 % vs. RT group 43 % ( SS ) .", "label": "", "metadata": {}, "score": "55.147827"}
{"text": "Assessments and evaluations .After RT all patients underwent follow - up visits on a regular basis .These visits were scheduled every 3 months for the first 2 years , twice a year until the 5th year and yearly thereafter .", "label": "", "metadata": {}, "score": "55.18008"}
{"text": "Outcome : 3-year PFS neoadjuvant 88 % vs control 59 % ( HR 0.49 , NS ) , 3-year OS 94 % vs 68 % ( HR 0.24 , SS ) .", "label": "", "metadata": {}, "score": "55.192257"}
{"text": "2005 Sep 20;23(27):6730 - 8 . )Median F / U 3.2 years .Outcome : 3-year DFS chemo - RT 72 % vs. RT 53 % ( SS ) ; OS 80 % vs. 65 % ( SS ) ; 2-year DM chemo - RT 13 % vs. RT alone 30 % ( SS ) .", "label": "", "metadata": {}, "score": "55.253372"}
{"text": "Eight to twelve weeks after the end of treatment a post - therapy baseline CT or MRI was performed .Time - to - event endpoints were calculated from end of RT until the date of event .", "label": "", "metadata": {}, "score": "55.34209"}
{"text": "( Solin LJ , Cancer .2005 Mar 15;103(6):1137 - 46 . )Retrospective .1003 women with mammo - detected DCIS , treated with BCS+RT in 10 institutions .", "label": "", "metadata": {}, "score": "55.387306"}
{"text": "Mean F / U 2 years .Outcome : 2-year LRFS 50 % , OS 50 % .By DVH coverage \" optimal \" 83 % vs \" suboptimal \" 17 % ( SS ) .", "label": "", "metadata": {}, "score": "55.391594"}
{"text": "Cancer .2005 May 1;103(9):1778 - 84 .13 pts with DCIS later identified in breast biopsy originally thought benign .6 pts developed invasive cancer ( OR 13.5 ) and 10 pts developed either an invasive or in - situ lesion ( OR was 20.1 ) .", "label": "", "metadata": {}, "score": "55.439384"}
{"text": "Median F / U 10.5 yrs .10-year LR : 26 % BCS alone vs 15 % BCS+RT ( SS ) , 47 % reduction .", "label": "", "metadata": {}, "score": "55.537125"}
{"text": "16 patients , mastectomy for DCIS , adjuvant RT .RT dose average 55.8 Gy ( 45 - 66.4 ) .Median F / U 4.7 years .", "label": "", "metadata": {}, "score": "55.58065"}
{"text": "When a pathologic confirmation was impossible or inconclusive , a clinical confirmation was used by radiologic correlation with subsequent follow - up ceCT at a minimum of 3-month intervals .", "label": "", "metadata": {}, "score": "55.62681"}
{"text": "2006 Feb 1;64(2):374 - 81 .Epub 2005 Oct 5 . )Retrospective .50 patients , T3-T4 NPC ( Stage III 28 % , Stage IVA / B 72 % ) .", "label": "", "metadata": {}, "score": "55.65866"}
{"text": "Tumors were assessed for histologic subtype , nuclear grade , comedonecrosis , maximal diameter , and margin width .RT decreased the recurrence rate for close or involved margins ; for intermediate or wide margins , was not statistically different .", "label": "", "metadata": {}, "score": "55.709435"}
{"text": "On statistical analysis , equivocal lesions were regarded as benign .Abnormal 18 F - FDG PET / CT lesions were assessed as benign or malignant with respect to their location , patterns of uptake , and SUV max .", "label": "", "metadata": {}, "score": "55.880745"}
{"text": "2002 Apr 15;94(8):2217 - 23 . )Median F / U 4.1 years .Outcome : 5-year OS induction chemo 60 % vs. RT alone 48 % ( NS ) ; DFS 55 % vs. 43 % ( NS ) .", "label": "", "metadata": {}, "score": "55.954357"}
{"text": "Thus , no significant interval change for at least 3-months of follow - up by ceCT was required to confirm the lesion of interest as clinically benign .", "label": "", "metadata": {}, "score": "55.987953"}
{"text": "Our patterns of failure analysis emphasizes the need to improve high - risk CTV target volume definition , as the majority of our locoregional recurrences occurred marginal to or outside of the high - risk CTV .", "label": "", "metadata": {}, "score": "55.997566"}
{"text": "In these studies , 18 F - FDG PET or PET / CT did not have a statistically significant advantage over ceCT in the diagnosis of primary tumors , but was valuable in identifying occult distant metastases which were not detected by conventional imaging .", "label": "", "metadata": {}, "score": "56.02471"}
{"text": "Population - based .21,249 patients with Stage IA - IC on TAH / BSO and pathologic staging , N0 endometrial adenocarcinoma .Adjuvant RT in 19 % ( 62 % EBRT , 18 % BT , 26 % EBRT+BT ) .", "label": "", "metadata": {}, "score": "56.05126"}
{"text": "Gynecol Oncol .2003 May;89(2):201 - 9 . )Median F / U 6.1 years . 8-year outcome : LRF : RT 4 % vs. control 15 % ( SS ) , majority failures after surgery only in vagina ; DM 10 % vs. 6 % ( NS ) ; OS RT 71 % vs. control 77 % ( NS ) .", "label": "", "metadata": {}, "score": "56.302147"}
{"text": "We demonstrated that 18 F - FDG PET / CT significantly improved the overall sensitivity of detecting BTC recurrences when ceCT was inconclusive and did not correspond to the clinical presentation .", "label": "", "metadata": {}, "score": "56.462807"}
{"text": "Closed early due to slow accrual .189 patients , WHO grade II - III , Stage T3 - 4N0 - 1 ( AJCC-5)(key problem locoregional failure ; see companion trial NPC-9901 ) .", "label": "", "metadata": {}, "score": "56.534554"}
{"text": "2005 Feb 20;23(6):1118 - 24 . )Outcome : 5-year DFS induction chemo 63 % vs. RT 58 % ( SS ) , OS 62 % vs. 58 % ( NS ) .", "label": "", "metadata": {}, "score": "56.67968"}
{"text": "Chemo completed by 55 % .1998 PMID 9552031 - \" Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer : phase III randomized Intergroup study 0099 .", "label": "", "metadata": {}, "score": "56.92202"}
{"text": "Outcome : DFS / PFS improved 2 years 37 % , 3 years 40 % , 4 years 34 % .OS improved 2 years 20 % ( NS ) , 3 years 19 % ( NS ) , 4 years 21 % ( SS ) .", "label": "", "metadata": {}, "score": "57.136486"}
{"text": "Median F / U 5.6 years .5-years ; 2005 PMID 15657403 -- \" Long - term survival after cisplatin - based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma : a pooled data analysis of two phase III trials . \"", "label": "", "metadata": {}, "score": "57.19856"}
{"text": "81 patients with uterine ( 88 % ) or cervical ( 12 % ) cancer .Primary endpoint : efficiency of supplementation .2010 PMID 20133068 -- \" Multicenter , Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology . \"", "label": "", "metadata": {}, "score": "57.223717"}
{"text": "Breast Cancer Res Treat 2002;76(suppl):S36 .Retrospective analysis .For DCIS with ER- , no benefit seen for tamoxifen .15 years - see \" NSABP B-17 & B-24 , Long Term ; 2011 \" .", "label": "", "metadata": {}, "score": "57.305786"}
{"text": "Outcome : 3-year OS was 93 % and DFS was 65 % ; both substantially better than historical controls .Conclusion : INT 0099 regimen should be standard of care .", "label": "", "metadata": {}, "score": "57.336723"}
{"text": "Specifically , Radan et al described patients with breast cancer and rising tumor markers in which 18 F - FDG PET / CT was superior to CT for diagnosis of tumor recurrence , and led to changes in the subsequent clinical management of 51 % of the patients [ 19 ] .", "label": "", "metadata": {}, "score": "57.356346"}
{"text": "In relation to CTV54 and CTV60 - 66 or CTV72 coverage the recurrences showed an unexpected variety ( Table 3 ) with \" marginal \" and \" out \" volume recurrences in relation to both CTVs .", "label": "", "metadata": {}, "score": "57.36847"}
{"text": "Surgical margin : 55 close SM , 4 SM+ .Median F / U 8 years .Outcome : Chest wall recurrence 1/59 close / positive SM ( patient had 4 cm , G3 DCIS , SM 5 mm , skin - sparing mastectomy ) .", "label": "", "metadata": {}, "score": "57.394012"}
{"text": "The results are impressive at 8 years following treatment with relatively high local control and low morbidity at 15 % .This report is one of a few that discuss the radiation tolerance of the sacral nerve roots , and , we see here that in some patients it appears to be below 77.4 Gy .", "label": "", "metadata": {}, "score": "57.48564"}
{"text": "80 patients .Stage I - IV M0 .Arm 1 ) RT alone vs. Arm 2 ) Neoadjuvant cisplatin 80 mg / m2 , 5-FU 800 mg / m2 q3 weeks x2 cycles .", "label": "", "metadata": {}, "score": "57.515495"}
{"text": "2008 Jun 3 .[ Epub ahead of print ] ) .Outcome : 5-year DFS RT 85 % vs. chemo - RT 82 % ( NS ) .", "label": "", "metadata": {}, "score": "57.662453"}
{"text": "221 patients , WHO II - III , T3 - 4 or N2 - 3 ( AJCC-5 ) .Arm 1 ) RT alone vs. Arm 2 ) RT + concurrent cisplatin 100 mg / m2 q3 weeks + adjuvant cisplatin 80 mg / m2 + 5-FU 1000 mg / m2 x3 cycles .", "label": "", "metadata": {}, "score": "57.741135"}
{"text": "( Cuzick J , Lancet .2011 Jan;12(1):21 - 9 . )Mean F / U 12.7 years .Conclusion : RT can be recommended for DCIS , there is little evidence to recommend tamoxifen for prevention of ipsilateral invasive disease .", "label": "", "metadata": {}, "score": "57.75728"}
{"text": "These rates vary widely with geography .Unfortunately , there are no commonly accepted guidelines to help stratify patients .NSABP B-17 & B-24 , Long Term ; 2011 ( 1985 - 1994 ) PMID 21398619 -- \" Long - Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS . \"", "label": "", "metadata": {}, "score": "57.794266"}
{"text": "165 local recurrences ( 103 - excision alone , 62 - RT ) .Original treatment recommendations : excision alone for those who score 4 - 6 ; RT for those who score 7 - 9 ; mastectomy for those who score 10 - 12 .", "label": "", "metadata": {}, "score": "57.87603"}
{"text": "Median F / U 6 years .Outcome : Addition of chemo absolute survival benefit of 6 % at 5 years ( 56 % to 62 % ) , absolute EFS benefit of 10 % ( 42 % to 52 % ) .", "label": "", "metadata": {}, "score": "57.887634"}
{"text": "Creutzberg CL et al .J Clin Oncol .2004 Apr 1;22(7):1234 - 41 .Analysis of 99 IC G3 registered but ineligible patients , treated per same protocol .", "label": "", "metadata": {}, "score": "57.92756"}
{"text": "2010 Feb 2 . [ Epub ahead of print ] ) .Outcome : Selenium level post RT significantly higher with supplement .Grade 2 + diarrhea selenium 20 % vs no selenium 44 % ( SS ) .", "label": "", "metadata": {}, "score": "57.956627"}
{"text": "The FTB is uniformly assigned doses around 70 Gy in case of gross residual disease and 66 Gy in R1 except by Chen et al .", "label": "", "metadata": {}, "score": "58.107414"}
{"text": "1999 Apr;93(4):599 - 602 . )Purpose : to evaluate the results of patients treated with EBRT alone without VB .Retrospective .61 pts with Stage IC .", "label": "", "metadata": {}, "score": "58.147667"}
{"text": "Criticisms : margins status criteria , no radiographic eval postop(silverstein ) .EORTC 10853 ( 1986 - 1996 ) -- RT vs. No RT .Randomized .", "label": "", "metadata": {}, "score": "58.210403"}
{"text": "( No Authors , Int J Radiat Oncol Biol Phys .1996 Jun 1;35(3):463 - 9 . )Median F / U 4.1 years .No difference in OS .", "label": "", "metadata": {}, "score": "58.22113"}
{"text": "2012 Feb 1;82(2):e153 - 8 . )Retrospective .220 pts , all treated with lumpectomy + RT .36 % received a boost .Median f / u 46 mo .", "label": "", "metadata": {}, "score": "58.27688"}
{"text": "2002 Dec;6(6):337 - 48 . )Treatment planning .5 patients with T4N0 NPC , treated with concurrent chemo - RT using combined photon / proton beams .", "label": "", "metadata": {}, "score": "58.28276"}
{"text": "At a median follow - up of 2.3 ( range , 1.1 - 4.6 ) years the 3-year LRRFS , DMFS and OS estimates were 79 % , 90 % , and 73 % respectively .", "label": "", "metadata": {}, "score": "58.31842"}
{"text": "McNemar 's test and Fisher 's exact test were used to evaluate the efficacy of ceCT , 18 F - FDG PET / CT , and the combination .", "label": "", "metadata": {}, "score": "58.352654"}
{"text": "Outcome : Prescribed IMRT given to 84 % ; prescribed chemo 65 % .2-year LC 93 % , LRC 89 % , DMFR 85 % .", "label": "", "metadata": {}, "score": "58.536263"}
{"text": "During surveillance , the definitive diagnosis of suspicious lesions on contrast - enhanced CT ( ceCT ) scans as recurrent cancer can only be made by pathologic confirmation .", "label": "", "metadata": {}, "score": "58.66996"}
{"text": "Conclusion : Surgical margin status significant predictor for recurrence .Based on 3 randomized trials ( NSABP B-17 , EORTC 10853 , and UKCCCR ) , all subgroups ( as analyzed by multivariate analysis looking at individual variables ) benefit from RT .", "label": "", "metadata": {}, "score": "58.75129"}
{"text": "A Singaporean trial used the INT 0099 regimen , and again demonstrated a survival benefit .Concurrent chemo - RT is now considered a standard of care in Stage III - IV NPC ; given previously different staging , some IIB patients were included in the trials and may benefit from concurrent chemotherapy as well .", "label": "", "metadata": {}, "score": "58.752983"}
{"text": "Nevertheless , the prompt diagnosis of recurrent BTC could allow for prompt treatment and reduce the number of unnecessary interventions [ 2 ] .Therefore , the surveillance of BTC recurrence is important .", "label": "", "metadata": {}, "score": "58.768597"}
{"text": "Presence of comedo necrosis was categorized in the high grade group .Tamoxifen was allowed in those pts enrolled after 2000 ( about 30 % of pts received tamoxifen ) .", "label": "", "metadata": {}, "score": "58.800964"}
{"text": "348 patients , WHO grade II - III , T1 - 4N2-N3 ( AJCC-5)(key problem distant failure ; see companion trial NPC-9902 ) .", "label": "", "metadata": {}, "score": "58.883545"}
{"text": "103 institutions .IC 61 % , II 14 % , IIIA 13 % , IIIC 12 % .S / P TAH / BSO and surgical staging ( 96 % PLND , 29 % PALND ) .", "label": "", "metadata": {}, "score": "58.970573"}
{"text": "Our CTV definitions and dose prescriptions are almost identical to those reported by Sher et al .[ 13 ] , the relevant difference being that we prescribed 54 Gy to dissected and involved lymph node levels in the absence of ECE instead of 60 Gy .", "label": "", "metadata": {}, "score": "59.059002"}
{"text": "BACKGROUND AND PURPOSE : Paraclinoid aneurysms are an uncommon cause of aneurysmal SAH , and their treatment is challenging .To assess the effectiveness and safety of endovascular treatment of ruptured paraclinoid aneurysms , we performed a retrospective analysis of 33 patients .", "label": "", "metadata": {}, "score": "59.160652"}
{"text": "Distant metastasis .All patients who developed metastasis had also either local or regional recurrence .The 2- and 3-year DMFS estimates were both 90 % ( Figure 1B ) .", "label": "", "metadata": {}, "score": "59.264153"}
{"text": "Median retreatment dose 50 GyE ( 32 - 62 ) .Outcome : LC 45 % .5-year OS 31 % .Conclusion : Results appear superior to others using conventional photon therapy .", "label": "", "metadata": {}, "score": "59.314407"}
{"text": "( Johnson N , BJOG .2007 Nov;114(11):1313 - 20 .Epub 2007 Sep 5 . )Cochrane methodology .5 randomized trials .Low - risk disease ( IA , IBG1 - 2 ) : EBRT worsens survival ( OR for death without RT 0.71 , SS ) .", "label": "", "metadata": {}, "score": "59.34741"}
{"text": "Conclusion : Induction chemo - RT modest decrease in DFS , but no impact on OS .Concurrent chemo - RT should remain standard of care .", "label": "", "metadata": {}, "score": "59.378677"}
{"text": "7-years ; 2015 PMID 25605856 -- \" RTOG 9804 : a prospective randomized trial for good - risk ductal carcinoma in situ comparing radiotherapy with observation . \"", "label": "", "metadata": {}, "score": "59.469677"}
{"text": "SWH , EKC , JYJ , SAITYK , SW K , SWH and YJB treated many of the patients in this study .All authors read and approved the final manuscript .", "label": "", "metadata": {}, "score": "59.51483"}
{"text": "Evaluated surgical margin and treatments ( BCS alone , BCS + RT , mastectomy ) , stratified by surgeon .Median F / U 5 years .", "label": "", "metadata": {}, "score": "59.52933"}
{"text": "RT : benefit for invasive IBTR ( 3 % vs. 6 % , HR 0.45 ) , and benefit for ipsilateral DCIS ( 3 % vs. 7 % , HR 0.36 ) , no impact on contralateral events .", "label": "", "metadata": {}, "score": "59.579224"}
{"text": "RT : benefit for invasive IBTR ( 3 % vs. 6 % , HR 0.45 ) , and benefit for ipsilateral DCIS ( 3 % vs. 7 % , HR 0.36 ) , no impact on contralateral events .", "label": "", "metadata": {}, "score": "59.579224"}
{"text": "CR obtained in 31 of 35 ( 89 % ) , with long term control in 24 of 31 ( 77 % ) .Total long term control rate is thus 24/35 ( 68 % ) .", "label": "", "metadata": {}, "score": "59.74276"}
{"text": "View Article .Dawson LA , Anzai Y , Marsh L , Martel MK , Paulino A , Ship JA , Eisbruch A : Patterns of local - regional recurrence following parotid - sparing conformal and segmental intensity - modulated radiotherapy for head and neck cancer .", "label": "", "metadata": {}, "score": "59.99574"}
{"text": "Closed due to nonaccrual .RTOG 97 - 08 ( 1997 - 99 ) .Phase II .Post - operative chemo+RT for \" high risk \" endometrial adenocarcinoma ( Stage IC G2 - 3 , II , III ) .", "label": "", "metadata": {}, "score": "60.038063"}
{"text": "( Morrow CP , Gynecol Oncol .1990 Feb;36(2):166 - 71 . )Toxicity : 7 % SBO ; treatment - related deaths DOX 25 % vs. RT 2 % .", "label": "", "metadata": {}, "score": "60.043556"}
{"text": "Either histopathologic or clinical confirmation after 18 F - FDG PET / CT was considered the standard of reference .When a pathologic confirmation was possible , it was considered the standard of reference .", "label": "", "metadata": {}, "score": "60.0944"}
{"text": "2009 Jun 29 .[ Epub ahead of print ] ) .Phase II .Multi - institutional IMRT use .68 patients , Stage I - IVb NPC ( 94 % WHO type 2 - 3 ) .", "label": "", "metadata": {}, "score": "60.274746"}
{"text": "All patients with locally advanced ( AJCC stage III / IV ) or high - risk OCC ( AJCC stage II ) who underwent postoperative IMRT at our institution between December 2006 and July 2010 were retrospectively analyzed .", "label": "", "metadata": {}, "score": "60.35128"}
{"text": "5-year DFS after mastectomy ( 99.3 % ) , lumpectomy + RT ( 94.5 % ) , and lumpectomy without RT ( 82.4 % ) significantly different by surgeon .", "label": "", "metadata": {}, "score": "60.53365"}
{"text": "Grade 3 - 4 complications 3 % vs. 0 % .By site : GI 20 % ( 3 % severe ) ; GU 8 % ( no severe ) ; bone 2 % ( no severe ) ; vagina 1 % ( no severe ) .", "label": "", "metadata": {}, "score": "60.77955"}
{"text": "Conclusion : \" Mastectomy for pure DCIS resulted in a low rate of local or distant recurrences .Even with positive or close mastectomy margins , the rates of chest wall recurrences were so low that PMRT is likely not warranted .", "label": "", "metadata": {}, "score": "60.78848"}
{"text": "The presence of necrosis significantly correlated with LR .Conclusion : Our results suggest that the use of a radiotherapy boost improves local control in DCIS and may outweigh the poor prognostic effect of necrosis .", "label": "", "metadata": {}, "score": "60.90462"}
{"text": "OS 83 % , 73 % , 87 % , 88 % ( NS ) .Toxicity Grade 3 - 5 : Acute : RT 55 % , AFRT 70 % , chemo - RT 83 % , chemo - AFRT 86 % ( concurrent chemo SS worse ) .", "label": "", "metadata": {}, "score": "61.030365"}
{"text": "1999 Jun 12;353(9169):1993 - 2000 . )Median F / U 6.2 years .5-year BCA events : 13.4 % vs tamoxifen 8.2 % ( SS ) , ipsilateral 9.5 % vs. 6.0 % ( SS ) , contralateral 3.4 % vs. 2.0 % ( SS ) .", "label": "", "metadata": {}, "score": "61.04596"}
{"text": "J Clin Oncol .1988 Sep;6(9):1401 - 10 . )Outcome : 4-year RFS observation 56 % vs. chemo 58 % ( NS ) , no difference in OS ; Similar pattern of failure with distant mets in about 50 % who failed .", "label": "", "metadata": {}, "score": "61.050694"}
{"text": "2008 Mar 10;26(8):1247 - 52 .Epub 2008 Feb 4 . )No difference in DMFS .No group defined by stratification variables that had low risk without RT .", "label": "", "metadata": {}, "score": "61.052303"}
{"text": "Conclusion : Patients in NSABP B-24 with ER - positive DCIS receiving adjuvant tamoxifen after standard therapy showed significant reductions in subsequent breast cancer .UKCCCR ( 1990 - 1998 ) -- Observation vs RT vs TAM vs RT + TAM .", "label": "", "metadata": {}, "score": "61.067886"}
{"text": "\" The fact that a majority of true local relapses occur in close proximity to the tumor bed , along with available pathologic data demonstrating minimal microscopic tumor burden more than 1 to 2 cm beyond the primary tumor , provides a rationale for more localized treatment in selected patients .", "label": "", "metadata": {}, "score": "61.153294"}
{"text": "In intermediate - risk , both LND and RT were associated with higher survival ; there were no differences between RT modalities .In high risk , both LND and RT were associated with increased survival ; VB alone was inferior to WPRT if LND was not performed .", "label": "", "metadata": {}, "score": "61.19832"}
{"text": "International Nasopharynx Cancer Study Group : VUMCA I ( 1989 - 1993 ) -- cisplatin , epirubicin , bleomycin .Randomized .339 patients .Undifferentiated carcinoma ( WHO 2 or 3 ) , any T stage , N2 - 3 , M0 .", "label": "", "metadata": {}, "score": "61.265022"}
{"text": "In this context , when ceCT is inconclusive for identifying post - operative changes and the lymph nodes are of borderline size , a discernible role for 18 F - FDG PET / CT is feasible .", "label": "", "metadata": {}, "score": "61.354782"}
{"text": "One of these patients for example recurred in the FTB and in the ipsilateral dissected and contralateral not dissected neck with 6 volumes of tumor all within CTV54 , whereas 2 recurrences in the contralateral Level I were not covered by CTV60 - 66 .", "label": "", "metadata": {}, "score": "61.539764"}
{"text": "( Pan JJ , J Clin Oncol .2008 Dec 22 .[ Epub ahead of print ] )Median F / U 5.1 years .", "label": "", "metadata": {}, "score": "61.566597"}
{"text": "Therefore , we conducted this study to evaluate and compare the diagnostic validity of ceCT and 18 F - FDG PET / CT in the assessment of BTC recurrence after curative surgery .", "label": "", "metadata": {}, "score": "61.698982"}
{"text": "2006 Jan 1;64(1):47 - 56 . ) 8 trials , 1753 patients ( concurrent : INT 0099 , PWH - QEH Hong Kong , QMH Hong Kong , induction : PWH Hong Kong , AOCOA , VUMCA , Hokkaido , adjuvant : Taiwan ) .", "label": "", "metadata": {}, "score": "61.82245"}
{"text": "[20,23,24 ] .Search for an Alternative to WBI .Based on the numerous randomized studies noted above , it is standard of care for all women , regardless of age or tumor size , to receive radiotherapy in the setting of BCT to reduce local recurrence .", "label": "", "metadata": {}, "score": "61.908634"}
{"text": "18 F - FDG PET / CT alone is not more sensitive or specific than ceCT in the detection of recurrent BTC after curative surgery .", "label": "", "metadata": {}, "score": "62.000893"}
{"text": "RTOG 99 - 05 ( 1999 - 2003 ) .Randomized .High risk endometrial CA ( Stage IC G2 - 3 , II , III ) .", "label": "", "metadata": {}, "score": "62.00539"}
{"text": "Toxicity : Acute G1 - 2 at completion of RT VBT 13 % vs EBRT 54 % .Conclusion : VBT is effective , with fewer toxic effects .", "label": "", "metadata": {}, "score": "62.026978"}
{"text": "Pts with ER - positive DCIS treated with Tam showed significant decreases in subsequent breast cancer at 10 yrs ( HR 0.49 ) .Similar results were seen when ipsilateral and contralateral , invasive and noninvasive , breast cancers were considered separately .", "label": "", "metadata": {}, "score": "62.074944"}
{"text": "Although there was no compromise in survival with the omission of radiation in either trial , these studies were not powered sufficiently to detect small benefits in survival .", "label": "", "metadata": {}, "score": "62.080086"}
{"text": "PLND 82 % .Chemo 55 % .Outcome : 2 year vaginal cuff control 94 % , pelvic control 87 % , locoregional control 81 % , DFS 66 % , OS 79 % .", "label": "", "metadata": {}, "score": "62.08187"}
{"text": "2009 Nov 15;75(4):1021 - 8 .Epub 2009 Apr 20 . )Retrospective .Re - excision 29 % or RT + boost 71 % .", "label": "", "metadata": {}, "score": "62.12933"}
{"text": "Discussion .Since 2007 the outcome and patterns of failure of postoperative IMRT for OCC have been described by others [ 7 - 13 ] .", "label": "", "metadata": {}, "score": "62.13111"}
{"text": "However , an additional 18 F - FDG PET / CT on ceCT significantly improves the sensitivity of detecting recurrences .18 F - FDG PET / CT biliary tract cancer surveillance recurrence .", "label": "", "metadata": {}, "score": "62.140827"}
{"text": "Conclusion : Preliminary , concurrent chemo with accelerated fractionation could significantly improve local tumor control .Hong Kong NPC-9901 ( N - disease ) ( 1999 - 2004 ) .", "label": "", "metadata": {}, "score": "62.154808"}
{"text": "PubMed View Article .Mittra E , El - Maghraby T , Rodriguez CA , Quon A , Ross McDougall I , Gambhir SS , Iagaru A : Efficacy of ( 18)F - FDG PET / CT in the evaluation of patients with recurrent cervical carcinoma .", "label": "", "metadata": {}, "score": "62.20066"}
{"text": "We evaluated patients , who came to hospital with a documented recurrence of AF , or had a registered episode of AF on the 24-hour Holter 6 weeks after PVI and compared it with long - term outcome ... .", "label": "", "metadata": {}, "score": "62.221954"}
{"text": "High dose photon / proton RT can be delivered to spine sarcomas .Morbidity is acceptable , and the local control is encouraging .Results are durable but occasional late recurrences do occur .", "label": "", "metadata": {}, "score": "62.31922"}
{"text": "2005 Apr 6;97(7):536 - 9 . )Median F / U 5.5 years .Subgroup analysis no benefit for T1 - 2 , but benefit for T3 - 4 ( HR 0.51 ) .", "label": "", "metadata": {}, "score": "62.358543"}
{"text": "Vaginal Relapse / Salvage , 2003 PMID 12713981 Full Text - \" Survival after relapse in patients with endometrial cancer : results from a randomized trial . \"", "label": "", "metadata": {}, "score": "62.36457"}
{"text": "4-years ; 1988 PMID 3047335 - \" Adjuvant chemotherapy with vincristine , cyclophosphamide , and doxorubicin after radiotherapy in local - regional nasopharyngeal cancer : results of a 4-year multicenter randomized study . \"", "label": "", "metadata": {}, "score": "62.418518"}
{"text": "2-years ; 1995 PMID 7558945 - \" A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma . \"( Chan AT , Int J Radiat Oncol Biol Phys .", "label": "", "metadata": {}, "score": "62.467705"}
{"text": "2005Nov 1;63(3):834 - 8 . )Central pathology review for 569 patients ( 80 % ) .Poor reproducibility for G1 vs. G2 .LVI poor prognosis for DM .", "label": "", "metadata": {}, "score": "62.469776"}
{"text": "2006 Aug;7(8):652 - 6 . )Retrospective .373 women age 45 or younger from 18 institutions .15 % no RT , 45 % RT 50 Gy , 40 % RT 50 Gy + 10 Gy boost .", "label": "", "metadata": {}, "score": "62.540268"}
{"text": "Dose 70 - 74 Gy primary tumor and LN+ , 50 - 60 Gy N0 neck .Chemo completed by 94 % patients .5-years ; 2003 PMID 12586799 -- \" Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma : positive effect on overall and progression - free survival . \"", "label": "", "metadata": {}, "score": "62.606064"}
{"text": "PubMed View Article .Turaka A , Li T , Sharma NK , Li L , Nicolaou N , Mehra R , Burtness B , Cohen RB , Lango MN , Horwitz EM , Ridge JA , Feigenberg SJ : Increased recurrences using intensity - modulated radiation therapy in the postoperative setting .", "label": "", "metadata": {}, "score": "62.65882"}
{"text": "5-year LRF RT 28 % vs RT + rAd - p53 3 % ( SS ) ; 5-year DFS 57 % vs. 67 % ( NS ) ; 5-year OS 59 % vs. 67 % ( NS ) .", "label": "", "metadata": {}, "score": "62.69211"}
{"text": "82 patients with NPC .Arm 1 ) RT 70/35 alone vs. Arm 2 ) RT + recombinant adenovirus - p53 ( rAd - p53 ) injected intratumorally QW x8 .", "label": "", "metadata": {}, "score": "62.7539"}
{"text": "286 patients .Arm 1 ) neoadjuvant cisplatin 60 mg / m2 + epirubicin 110 mg / m2 x2 - 3 cycles followed by RT vs. Arm 2 ) RT alone .", "label": "", "metadata": {}, "score": "62.967712"}
{"text": "( Al - Sarraf M , Cancer .1987 Jan 15;59(2):259 - 65 . )Severe toxicity : stomatitis 31 % , leukopenia 11 % , anemia 8 % , N / V 6 % .", "label": "", "metadata": {}, "score": "63.11613"}
{"text": "2011May 1;29(13):1692 - 700 .Epub 2011 Mar 28 . )-- Mean f / u 13.3 yrs .15 yr LRR 5.8 % ( RT ) vs 15.5 % ( no RT ) ; OS 52 % vs 60 % , NS .", "label": "", "metadata": {}, "score": "63.191803"}
{"text": "Score 1 - 3 for each to arrive at a total score of 3 - 9 .Evaluated 333 pts treated with excision alone or excision + RT . .", "label": "", "metadata": {}, "score": "63.25015"}
{"text": "3-years ; 2005 PMID 16192584 -- \" Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally - advanced nasopharyngeal carcinoma : NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group . \"", "label": "", "metadata": {}, "score": "63.308777"}
{"text": "Tumor marker and 18 F - FDG uptake .When there was an indication for 18 F - FDG PET / CT , 14 patients had elevated CA19 - 9 levels compared to post - operative levels ( Table 2 ) .", "label": "", "metadata": {}, "score": "63.46465"}
{"text": "( The drop was from a decrease in the use of WPRT .The use of VB alone and combination EBRT+VB remained stable . )The use of LND increased : 16.2 % to 59.5 % .", "label": "", "metadata": {}, "score": "63.472183"}
{"text": "PubMed View Article .Radan L , Ben - Haim S , Bar - Shalom R , Guralnik L , Israel O : The role of FDG - PET / CT in suspected recurrence of breast cancer .", "label": "", "metadata": {}, "score": "63.499645"}
{"text": "Randomized .154 patients .Stage IV M0 ( AJCC 1992 ) .Arm 1 ) RT 70 - 72 Gy vs. Arm 2 ) weekly cisplatin 20 mg / m2 , 5-FU 2200 mg / m2 , leucovorin 120 mg / m2 x9 weeks .", "label": "", "metadata": {}, "score": "63.532455"}
{"text": "10-years ; 2001 PMID 11498833 -- \" Prevention of invasive breast cancer in women with ductal carcinoma in situ : an update of the national surgical adjuvant breast and bowel project experience . \"", "label": "", "metadata": {}, "score": "63.538666"}
{"text": "Conclusion : Adjuvant chemo after RT offers no benefit for OS or RFS .Italian NRC ( 1979 - 83 ) -- observation vs. vincristine / cyclophosphamide / adriamycin .", "label": "", "metadata": {}, "score": "63.54316"}
{"text": "PubMed View Article .Anderson CD , Rice MH , Pinson CW , Chapman WC , Chari RS , Delbeke D : Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma .", "label": "", "metadata": {}, "score": "63.560608"}
{"text": "RT 68 - 72 Gy primary tumor , involved neck 60 - 62 Gy , uninvolved neck 60 Gy .If residual tumor after RT , could boost 10 - 14 Gy EBRT or 20 - 24 Gy HDR in 4 - 5 fractions .", "label": "", "metadata": {}, "score": "63.58808"}
{"text": "2010 Mar;116(3):293 - 4 .Epub 2009 Nov 7 . )Two different questions , but due to overlap do n't answer either one .Randomized .", "label": "", "metadata": {}, "score": "63.65685"}
{"text": "2011 Mar 16;103(6):478 - 88 .Epub 2011 Mar 11 . )Joint analysis of 2 trials .Median F / U B17 17.2 years and B-24 13.6 years .", "label": "", "metadata": {}, "score": "63.682144"}
{"text": "In the high - risk group , in the absence of LND , only WPRT is associated with increased survival .LND was also associated with increased survival . \"", "label": "", "metadata": {}, "score": "63.687653"}
{"text": "2010 PMID 20619634 -- \" Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomised studies . \"( Hogberg T , Eur J Cancer .", "label": "", "metadata": {}, "score": "63.716187"}
{"text": "Outcome : VBT better social functioning ( SS ) , and significantly improved diarrhea , fecal leakage , need to stay close to the toilet , and limitation of daily activities due to bowel symptoms ( SS ) .", "label": "", "metadata": {}, "score": "63.724483"}
{"text": "1895 patients with DCIS , treated by BCS and RT .70 % treated with hypofractionated regimens ( 40 - 44 Gy in 16 fxs ) .", "label": "", "metadata": {}, "score": "63.825523"}
{"text": "Cisplatin given every 3 weeks at 100 mg / m2 x 3 cycles .Then adjuvant chemo began 4 weeks after finishing RT : cisplatin 80 mg / m2 and 5-FU 1000 mg / m2/d by 96-hr infusion q4w x 3 cycles .", "label": "", "metadata": {}, "score": "63.88511"}
{"text": "There is no benefit on OS or DFSS , and absolute benefit for isolated local recurrence is small and not without toxicity .ASTEC PLND ; 2009 PMID 19070889 -- \" Efficacy of systematic pelvic lymphadenectomy in endometrial cancer ( MRC ASTEC trial ) : a randomised study . \"", "label": "", "metadata": {}, "score": "64.00197"}
{"text": "Patients with high - grade lesions had a much higher rate , suggesting that excision alone is inadequate treatment . \" Comment : pathologic assessment included \" complete sequential tissue processing \" .", "label": "", "metadata": {}, "score": "64.0747"}
{"text": "2009 Jul 20;27(21):3547 - 56 .Epub 2009 Jun 22 . )QoL evaluated by EORTC QoL - C30 , PR-25 , and OV-28 questionnaires .", "label": "", "metadata": {}, "score": "64.10591"}
{"text": "( McCloskey SA , Gynecol Oncol .2010 Mar;116(3):404 - 7 .Epub 2009 Nov 27 . )Retrospective .PLND in 46 % .ICG3 16 % ; LVI+ 18 % .", "label": "", "metadata": {}, "score": "64.16036"}
{"text": "The decision to do selective neck dissections in cases with cN0 or in the contralateral node negative neck was at the discretion of the head and neck surgeon .", "label": "", "metadata": {}, "score": "64.190216"}
{"text": "Percentages were rounded to reach 100 % for every symptom .The highest grade of acute toxicity was : grade 2 in 14 patients ( 27 % ) ; grade 3 in 35 patients ( 66 % ) .", "label": "", "metadata": {}, "score": "64.21406"}
{"text": "2003 Jul 12;362(9378):95 - 102 . )Mean F / U 4.4 years .Outcome : Breast events : OBS 22 % vs. TAM alone 18 % vs. RT alone 8 % vs. TAM+RT 6 % .", "label": "", "metadata": {}, "score": "64.32124"}
{"text": "2003 Jul 12;362(9378):95 - 102 . )Mean F / U 4.4 years .Outcome : Breast events : OBS 22 % vs. TAM alone 18 % vs. RT alone 8 % vs. TAM+RT 6 % .", "label": "", "metadata": {}, "score": "64.32124"}
{"text": "N - classification was the only significant prognostic factor for both LRRFS and OS in multivariate analysis , consistent with the findings of Chen et al .", "label": "", "metadata": {}, "score": "64.62942"}
{"text": "However , a re - analysis of the data suggests that concurrent chemo - RT is only beneficial for \" low - risk \" advanced stage patients . \"", "label": "", "metadata": {}, "score": "64.64482"}
{"text": "American Society of Breast Surgeons ; 2010 ( 2002 - 2004 )PMID 20577822 -- \" Update on DCIS Outcomes from the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial . \"", "label": "", "metadata": {}, "score": "64.66359"}
{"text": "Unfortunately , the majority of data regarding APBI involves single - institution , nonrandomized studies with small patient populations .While these data are promising , it is clear that to firmly establish APBI as an acceptable alternative to WBI , prospective randomized studies are necessary .", "label": "", "metadata": {}, "score": "64.71473"}
{"text": "5-years , 2000 PMID 10791524 - \" Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma : multicentre randomised trial .", "label": "", "metadata": {}, "score": "64.72299"}
{"text": "Conclusion : Boost had no significant impact on recurrence .Rare Cancer Network ( 1978 - 2004 ) PMID 16887482 -- \" Boost radiotherapy in young women with ductal carcinoma in situ : a multicentre , retrospective study of the Rare Cancer Network . \"", "label": "", "metadata": {}, "score": "64.76802"}
{"text": "Accelerated same regimen but 6 days / week .Technique 2D or 3D - CRT or IMRT boost .Concurrent chemo cisplatin 100 mg / m2 q3 weeks , adjuvant chemo cisplatin 80 mg / m2 + 5-FU 1000 mg / m2 . 3-years ; 2006 PMID 16904519 -- \" Preliminary results of a randomized study ( NPC-9902 Trial ) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma . \"", "label": "", "metadata": {}, "score": "64.79283"}
{"text": "Conclusion : \" For patients with DCIS selected for favorable clinical and pathologic characteristics and treated with excision without radiation , the risks of developing an IBE and an invasive IBE increased through 12 years of follow - up , without plateau . \" MSKCC : 10 year IBTR ( lumpectomy + /- RT ) : SM close 28 % vs SM medium 21 % vs SM wide 19 % .", "label": "", "metadata": {}, "score": "65.03592"}
{"text": "2009 Apr 1;27(10):1615 - 20 .Epub 2009 Mar 2 . )Meta - analysis .4,660 patients , 22 trials evaluating BCS and RT . .", "label": "", "metadata": {}, "score": "65.087746"}
{"text": "However , our data do compare favorably with the toxicity rates outlined by Sher et al . assessed by CTCAE version 4.0 .[ 13 ] .", "label": "", "metadata": {}, "score": "65.10008"}
{"text": "Radiation therapy was delivered with a combined proton and photon technique .Proton therapy was passively scattered .Results .A total of 50 patients ( 29 chordoma , 14 chondrosarcoma , 7 other ) were treated between 1997 and 2005 .", "label": "", "metadata": {}, "score": "65.15866"}
{"text": "Corvera CU , Blumgart LH , Akhurst T , DeMatteo RP , D'Angelica M , Fong Y , Jarnagin WR : 18F - fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer .", "label": "", "metadata": {}, "score": "65.17763"}
{"text": "Conclusion : Study did not demonstrate superiority of VCB / C to PXRT .JGOG 2033 ( 1994 - 2000 ) -- adjuvant pelvic RT vs. adjuvant cisplatin / doxorubicin / cyclophosphamide .", "label": "", "metadata": {}, "score": "65.25646"}
{"text": "Conclusion : No benefit for EBRT after vaginal BT , except for Stage IC G3 patients .Risk of Vaginal Relapse .In PORTEC : risk of vaginal relapse in surgery only arm was IBG2 5 % , IBG3 14 % , ICG1 10 % , and ICG2 13 % ( personnal communication in PMID 16814156 ) .", "label": "", "metadata": {}, "score": "65.351974"}
{"text": "Late toxicity at last follow - up visit was also assessed to determine whether the late toxicity persisted or was transient .Time - to - event endpoints were estimated using the Kaplan Meier method .", "label": "", "metadata": {}, "score": "65.39967"}
{"text": "Anton A W Mulder .Summary .Publications .Early recurrence of atrial fibrillation as a predictor for 1-year efficacy after successful phased RF pulmonary vein isolation : evaluation of complaints and multiple Holter recordings .", "label": "", "metadata": {}, "score": "65.44969"}
{"text": "Post Operative Radiation Therapy in Endometrial Carcinoma . \"Creutzberg CL et al .Lancet .2000 Apr 22;355(9213):1404 - 11 .Median F / U 4.3 years .", "label": "", "metadata": {}, "score": "65.46582"}
{"text": "Randomized .Surgery + RT ( whole pelvis 50 Gy ; if PA LN+ then PA field to top of T12 45/30 ) .Arm 1 ) observation vs. Arm 2 ) doxorubicin .", "label": "", "metadata": {}, "score": "65.542816"}
{"text": "Anton A W Mulder Department of Cardiology , St Antonius Hospital , Nieuwegein , The Netherlands Pacing Clin Electrophysiol 35:164 - 9 .We evaluated the influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after a single PVI at 12 months ... .", "label": "", "metadata": {}, "score": "65.58978"}
{"text": "Patients had no prior radiation .Some patients had dural plaque therapy .Patients with osteosarcoma and Ewing 's sarcoma received chemotherapy .CTV1 was defined as subclinical disease and generally included the entire vertebral body and hemi - sacral segment , areas of extraosseous extension with at least 1 - 1.5 cm , and scar coverage for patients receiving post - op RT depending on grade of tumor and length of scar .", "label": "", "metadata": {}, "score": "65.61489"}
{"text": "Toxicity : Grade 3 bowel toxicity RT 3 % vs. chemo - RT 9 % .Conclusion : Adjuvant interdigitated chemo - RT failed to improve OS or lower recurrence rate over EBRT alone .", "label": "", "metadata": {}, "score": "65.61936"}
{"text": "Nasopharynx CR 82 % .Conclusion : Concurrent cisplatin effective and safe in advanced H&N .NPC Subset ; 1990 PMID 2199621 -- \" Chemo - radiotherapy in patients with locally advanced nasopharyngeal carcinoma : a radiation therapy oncology group study . \"", "label": "", "metadata": {}, "score": "65.68756"}
{"text": "Comment : OS not primary survival , not powered for it .Primary end - point DFS , which was significantly better with RT .Norwegian Radium Hospital -- VBT alone vs VBT + EBRT .", "label": "", "metadata": {}, "score": "65.79772"}
{"text": "Comment : more patients at low risk for distant failure ; less active chemo combination .Queen Mary Hospital ; 2006 ( Hong Kong)(2000 - 2004 ) PMID 16213105 -- \" Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma . \"", "label": "", "metadata": {}, "score": "65.8483"}
{"text": "Then , all of the subjects rested quietly for 1 hour .A whole - body 18 F - FDG PET scan was performed from the skull base to the mid - thigh .", "label": "", "metadata": {}, "score": "65.869705"}
{"text": "TAH / BSO with washings , not allowed to have lymphadenectomy .Allowed adenocarcinoma and variants ( including papillary serous and clear cell ) .Randomized to postoperative EBRT 46 Gy vs no further therapy .", "label": "", "metadata": {}, "score": "65.87382"}
{"text": "5-years ; 2002 PMID 12001120 -- \" A prospective , randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma . \"", "label": "", "metadata": {}, "score": "66.00078"}
{"text": "Concerning side effects , the acute toxicity grading was 2 in 27 % of patients and 3 for 66 % .The late toxicity grading was 2 in 34 % of patients and 3 in 11 % .", "label": "", "metadata": {}, "score": "66.02255"}
{"text": "Conclusion : Statistically significant improvement in survival in Stage IC disease .U.Chicago ; 1999 ( 1986 - 95 ) PMID 10214841 PDF -- \" External pelvic radiation therapy in stage IC endometrial carcinoma . \"", "label": "", "metadata": {}, "score": "66.02296"}
{"text": "CONCLUSIONS : Ruptured paraclinoid aneurysms are challenging lesions from an endovascular and surgical point of view .Despite the high rate of recurrences , good clinical results and protection against rebleeding can be achieved with current endovascular techniques .", "label": "", "metadata": {}, "score": "66.023026"}
{"text": "( Hughes LL , J Clin Oncol . published online ahead of print Oct 13 2009 . )Prospective , non - randomized .670 pts .", "label": "", "metadata": {}, "score": "66.05433"}
{"text": "The primary treatment of tumors of the spine and paraspinal tissues is challenging ; surgical resection is the mainstay of treatment but negative margins are rarely obtained .", "label": "", "metadata": {}, "score": "66.08304"}
{"text": "Tamoxifen randomization : no impact on invasive IBTR ( 7 % vs. 7 % ) , no impact on ipsilateral DCIS ( 7 % vs. 10 % ) , benefit for bilateral DCIS ( 7 % vs 11 % , HR 0.68 ) .", "label": "", "metadata": {}, "score": "66.125114"}
{"text": "Tamoxifen randomization : no impact on invasive IBTR ( 7 % vs. 7 % ) , no impact on ipsilateral DCIS ( 7 % vs. 10 % ) , benefit for bilateral DCIS ( 7 % vs 11 % , HR 0.68 ) .", "label": "", "metadata": {}, "score": "66.125114"}
{"text": "In a final adjustment all PTVs were set back from the skin surface 3 - 5 mm to allow for dose build - up except where the skin was deemed to be at risk of harbouring microscopic tumor e.g. the neck dissection scar in case of tumor spillage .", "label": "", "metadata": {}, "score": "66.16066"}
{"text": "RT 1995 - 1997 62.5/25 split course with 1 week break ; 1997 - 2001 68/34 primary and 66/33 neck .If parapharyngeal extension or residual disease , 10 Gy boost .", "label": "", "metadata": {}, "score": "66.1741"}
{"text": "RT 1995 - 1997 62.5/25 split course with 1 week break ; 1997 - 2001 68/34 primary and 66/33 neck .If parapharyngeal extension or residual disease , 10 Gy boost .", "label": "", "metadata": {}, "score": "66.1741"}
{"text": "Conclusion : Chemotherapy has small but significant benefit for OS and EFS , seen when administered concomitantly .Meta - analysis ; 2002 - PMID 12040275 - \" Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma : results of a meta - analysis of 1,528 patients from six randomized trials . \"", "label": "", "metadata": {}, "score": "66.18701"}
{"text": "This was the first trial to do so ; however , the RT only arm had an unexpectedly low survival , compared with results from RT alone in Asian ( endemic ) studies .", "label": "", "metadata": {}, "score": "66.18828"}
{"text": "References .Kramer S , Gelber RD , Snow JB , Marcial VA , Lowry LD , Davis LW , Chandler R : Combined radiation therapy and surgery in the management of head and neck cancer : final report of study 73 - 03 of the Radiation Therapy Oncology Group .", "label": "", "metadata": {}, "score": "66.24703"}
{"text": "5-year IBTR : invasive 10.5 % vs. 2.9 % , noninvasive 10.4 % to 7.5 % .8-years ; 1998 PMID 9469327 -- \" Lumpectomy and radiation therapy for the treatment of intraductal breast cancer : findings from National Surgical Adjuvant Breast and Bowel Project B-17 .", "label": "", "metadata": {}, "score": "66.26996"}
{"text": "PMID 18954711 -- \" Close or positive margins after mastectomy for DCIS : pattern of relapse and potential indications for radiotherapy . \"( Rashtian A , Int J Radiat Oncol Biol Phys .", "label": "", "metadata": {}, "score": "66.32404"}
{"text": "C to 100 !C. The temperature increase also allows a complete dissociation of the PVAc - Co dormant species into PVAc ! macroradicals and an almost quantitative grafting of eight PVAc chains onto C60 , leading to well - de ! ned C60(PVAc)8 octa - adducts .", "label": "", "metadata": {}, "score": "66.325195"}
{"text": "For the whole - body emission scan , 9-bed positions were examined at 3 min per step .CT and PET images were reconstructed onto a 512 \u00d7 512 matrix and a 128 \u00d7 128 matrix , respectively , and integrated after attenuation correction .", "label": "", "metadata": {}, "score": "66.33146"}
{"text": "( Wu SX , Int J Radiat Oncol Biol Phys .2007 Nov 1;69(3):761 - 9 . )Retrospective .Median dose 18/3 or 48/6 .", "label": "", "metadata": {}, "score": "66.34657"}
{"text": "Three different risk levels of clinical target volume ( CTV ) were defined .CTV72 was defined as gross tumor either due to early postoperative tumor progression with an additional isotropic margin of 1.5 cm and treated to 72 Gy .", "label": "", "metadata": {}, "score": "66.36288"}
{"text": "Rosewell Park ( PMID 19944453 ): 3.4 % in \" high risk \" patients treated with VB alone .PORTEC2 editorial ( PMID 20206759 ): Without any radiotherapy the risk of vaginal relapse is 10 - 14 % based on GOG92 and PORTEC .", "label": "", "metadata": {}, "score": "66.50485"}
{"text": "Affiliated with .Abstract .Background .Because of the late clinical presentation of biliary tract cancer ( BTC ) , only 10 % of patients are eligible for curative surgery .", "label": "", "metadata": {}, "score": "66.52007"}
{"text": "( Chino JP , Int J Radiat Oncol Biol Phys .2012 Apr 1;82(5):1872 - 9 . )SEER database .56,360 pts with Stage IA or IB ( using FIGO 2009 staging ) , negative lymph nodes if sampled .", "label": "", "metadata": {}, "score": "66.558846"}
{"text": "Favorable cosmesis 92 % ( minimum 5 year follow - up ) .Randomized .Did not require tumors to be ER+ .BCS + RT with or without tamoxifen .", "label": "", "metadata": {}, "score": "66.5718"}
{"text": "( Chan LW , Int J Radiat Oncol Biol Phys .2010 Jun 18 .[ Epub ahead of print ] ) .Retrospective .193 patients underwent mastectomy .", "label": "", "metadata": {}, "score": "66.65384"}
{"text": "The highest grade of late toxicity was : grade 2 in 18 patients ( 34 % ) ; grade 3 in 6 patients ( 11 % ) .", "label": "", "metadata": {}, "score": "66.681114"}
{"text": "The diagnostic validity of ceCT , 18 F - FDG PET / CT , and the combination was evaluated by comparison with the standard of reference .", "label": "", "metadata": {}, "score": "66.70881"}
{"text": "For the MDCT examinations , 3- to 5-mm slice thickness , and 3- to 5-mm reconstruction interval were used .CT images were obtained during the arterial and portal venous phases .", "label": "", "metadata": {}, "score": "66.73724"}
{"text": "Conclusion : Adequate tumor coverage important for LRC and survival .Lawrence Berkely Laboratory ; 1992 PMID 1618678 -- \" Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation . \"", "label": "", "metadata": {}, "score": "66.76682"}
{"text": "Lastly , the longer time interval between ceCT and PET / CT and the different characteristics of 3 CT scanners between the period of 2003 to 2008 might influence the results .", "label": "", "metadata": {}, "score": "66.78976"}
{"text": "PubMed View Article .Chen LB , Tong JL , Song HZ , Zhu H , Wang YC : ( 18)F - DG PET / CT in detection of recurrence and metastasis of colorectal cancer .", "label": "", "metadata": {}, "score": "66.81262"}
{"text": "\"Julien JP et al .Lancet .2000 Feb 12;355(9203):528 - 33 .Median follow - up 4.25 years .4 year LR - free rate : 84 % BCS vs. 91 % BCS + RT ( SS ) .", "label": "", "metadata": {}, "score": "66.857086"}
{"text": "Randomized .1701 women with DCIS .2x2 factorial ( 921 randomized to fully 2x2 , the remainder one way randomization to + /- RT or + /- TAM ) : BCS followed by 1 ) observation , 2 ) RT alone , 3 ) tamoxifen alone , or 4 ) RT + Tamoxifen .", "label": "", "metadata": {}, "score": "66.88701"}
{"text": "Additionally , as the most modern PET / CT scanners allow for fully diagnostic ceCT scans , contrast enhanced diagnostic PET / CT could be recommended as the primary modality of choice in case of suspected recurrence .", "label": "", "metadata": {}, "score": "66.91944"}
{"text": "Flow Diagram Showing Identification of Recurrence based on Imaging Finding .Discussion .The objective of the current study was to determine the clinical role of 18 F - FDG PET / CT in the assessment of BTC recurrences when clinicians suspected recurrence during surveillance based on symptoms , laboratory findings ( including tumor markers ) , and CT findings .", "label": "", "metadata": {}, "score": "66.95967"}
{"text": "ECE was detected in 11 flap reconstruction cases .Further patient and treatment characteristics are summarized in Table 1 .Median time between surgery and RT was 6.7 ( range , 3 - 17 ) weeks .", "label": "", "metadata": {}, "score": "67.09076"}
{"text": "High - risk disease ( ICG3 ) : EBRT offers DFS benefit ( OR 1.76 , SS ) , and benefits 1/10 women .Conclusion : Adjuvant EBRT should not be used for IA , IB , or IC G1 - 2 disease .", "label": "", "metadata": {}, "score": "67.12895"}
{"text": "A pilot study was performed by the MGH showing high rates of local control ( in 9 of 14 patients with chordomas and 6 of 6 patients which chondrosarcomas ) with a mean target dose of 73.9 Gy ( RBE ) ( Hug the Int .", "label": "", "metadata": {}, "score": "67.25435"}
{"text": "All p values were two - sided in tests and p values less than or equal to 0.05 were considered to be statistically significant .All analyses were performed using Stata 9.0 software ( Stata Corp , College Station , TX , USA ) .", "label": "", "metadata": {}, "score": "67.282364"}
{"text": "Conclusion : rAd - p53 was safe and biologically active , and improves tumor control and survival rate .784 patients .Induction cisplatin , bleomycin , 5-FU or cisplatin , epirubicin .", "label": "", "metadata": {}, "score": "67.351006"}
{"text": "Others reported ECE or positive margins and total treatment time as significant [ 8 , 11 ] .Table 5 .Treatment details and results of retrospective reports with postoperative IMRT in oral cavity cancer .", "label": "", "metadata": {}, "score": "67.35418"}
{"text": "IBTR SM- 13 % vs. SM+ 23 % ( SS ) .By margin status , if SM- boost 13 % vs no boost 13 % ( NS ) , if SM+ boost 21 % vs. no boost 26 % ( NS ) .", "label": "", "metadata": {}, "score": "67.36218"}
{"text": "[ 13,14 ] .As a result of these data , breast - conservation surgery followed by whole - breast irradiation ( BCS+RT ) became the standard of care for women with stage 0 , I , and II breast cancer .", "label": "", "metadata": {}, "score": "67.40871"}
{"text": "( Brown AP , Int J Radiat Oncol Biol Phys . 1989 Jun;16(6):1607 - 14 . )Treatment planning .Proton vs photon comparison .Outcome : Proton superior dose - distribution , increase 5 Gy in median tumor dose , substantial reduction in normal tissue dose .", "label": "", "metadata": {}, "score": "67.47454"}
{"text": "Risk of pelvic recurrence comparable to women treated with pelvic radaition but no lymph node dissection .Pelvic radiation should be considered based on clinical context .", "label": "", "metadata": {}, "score": "67.55893"}
{"text": "Jadvar H , Henderson RW , Conti PS : [ F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography : computed tomography in recurrent and metastatic cholangiocarcinoma .", "label": "", "metadata": {}, "score": "67.57329"}
{"text": "26 ] They further identified subgroups , such as women between 70 and 79 years with low comorbidities and those with lobular histology , who derived the greatest benefit from radiotherapy .", "label": "", "metadata": {}, "score": "67.64125"}
{"text": "2007 ASCO Abstract -- \" A randomized phase - III study on adjuvant treatment with radiation ( RT ) \u00b1 chemotherapy ( CT ) in early - stage high - risk endometrial cancer ( NSGO - EC-9501/EORTC 55991 ) . \"", "label": "", "metadata": {}, "score": "67.67095"}
{"text": "[ Epub ahead of print ] ) .MaNGO trial was same format , but enrolled primarily Stage IIB and III patients .Signficant OS benefit for chemo in endometrioid subset ( 5-year OS 69 % vs 80 % , SS ) but not in serous and clear cell subset ( NS ) .", "label": "", "metadata": {}, "score": "67.71669"}
{"text": "No difference in OS or distant mets .2000 PMID 10683002 - \" Radiotherapy in breast - conserving treatment for ductal carcinoma in situ : first results of the EORTC randomised phase III trial 10853 .", "label": "", "metadata": {}, "score": "67.73773"}
{"text": "15-year : OS 89 % , cause - specific 98 % , freedom from distant mets 97 % , freedom from LR 81 % .", "label": "", "metadata": {}, "score": "67.823166"}
{"text": "Phase III randomized clinical trials are currently underway to assess local control , acute and chronic toxicities , and quality of life associated with APBI compared to WBI .", "label": "", "metadata": {}, "score": "67.82997"}
{"text": "We evaluated ( pre)-procedural factors explaining the long - term outcome after PVI , using a ring - shaped multielectrode ablation catheter [ pulmonary vein ablation catheter ( PVAC ) ] ... .", "label": "", "metadata": {}, "score": "67.90311"}
{"text": "2 LF in the RT arm vs. 15 in the OBS arm : at 5 years 0.4 % RT vs. 3.2 % OBS .TAM was used in 62 % of women .", "label": "", "metadata": {}, "score": "67.91887"}
{"text": "2015 Mar 1;33(7):709 - 15 ) .NSABP B-17 .Randomized .818 women with DCIS , SM- .Treated with lumpectomy or lumpectomy + RT 50Gy ( no boost ) .", "label": "", "metadata": {}, "score": "68.09874"}
{"text": "PubMed View Article .Schoder H , Yeung HW , Gonen M , Kraus D , Larson SM : Head and neck cancer : clinical usefulness and accuracy of PET / CT image fusion .", "label": "", "metadata": {}, "score": "68.10214"}
{"text": "Obstet Gynecol .1980 Oct;56(4):419 - 27 . 9-year outcome : OS BT alone 90 % vs BT+EBRT 87 % ( NS ) .", "label": "", "metadata": {}, "score": "68.11583"}
{"text": "3-years ; 1998 PMID 9840526 -- \" Preliminary report of the Asian - Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma .", "label": "", "metadata": {}, "score": "68.12291"}
{"text": "PubMed View Article .Chen WC , Hwang TZ , Wang WH , Lu CH , Chen CC , Chen CM , Weng HH , Lai CH , Chen MF : Comparison between conventional and intensity - modulated post - operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity .", "label": "", "metadata": {}, "score": "68.12688"}
{"text": "Patients were staged according to the AJCC 2002 guidelines [ 14 ] .This study was approved by the local ethics committee .Treatment .Prior to start of any treatment , stage of disease , sequence of treatment and modalities were defined in the weekly interdisciplinary institutional head - and - neck tumorboard for all patients .", "label": "", "metadata": {}, "score": "68.1906"}
{"text": "Retrospective .A wide variety of treatments described .RTOG 0225( 2003 - 2005 )Protocol PMID 19564532 -- \" Intensity - Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma : Radiation Therapy Oncology Group Phase II Trial 0225 . \"", "label": "", "metadata": {}, "score": "68.20456"}
{"text": "Conclusion : Group 1 ( T1 - 2N0 - 1 ; all IIB ) relatively poor survival due to mets , improved with induction chemo .", "label": "", "metadata": {}, "score": "68.23094"}
{"text": "Loma Linda ; 1999 ( 1991 - 1997 )PMID 10551231 -- \" Nasopharyngeal carcinoma : repeat treatment with conformal proton therapy -- dose - volume histogram analysis . \"", "label": "", "metadata": {}, "score": "68.29878"}
{"text": "Updated Meta - analysis ( GOG99 , PORTEC1 , ASTEC / EN.5 ) : HR 1.04 for benefit of RT ( 0.84 - 1.29 , NS ) .", "label": "", "metadata": {}, "score": "68.30719"}
{"text": "( Dominguez FJ , Ann Surg Oncol .2008 Jan;15(1):268 - 73 .Epub 2007 Sep 22 . )Retrospective .179 patients , mastectomy with SLB for DCIS on intial biopsy .", "label": "", "metadata": {}, "score": "68.35449"}
{"text": "PubMed View Article .Lavaf A , Genden EM , Cesaretti JA , Packer S , Kao J : Adjuvant radiotherapy improves overall survival for patients with lymph node - positive head and neck squamous cell carcinoma .", "label": "", "metadata": {}, "score": "68.3611"}
{"text": "Conclusion : Neoadjuvant chemo did n't improve DFS or OS .Asian - Oceanic Clinical Oncology Association ( AOCOA ) ( 1989 - 1993 ) -- cisplatin , epirubicin .", "label": "", "metadata": {}, "score": "68.37342"}
{"text": "Retrospective analysis .1569/1799 patients analyzed , 692 ( 44 % ) received optional boost .Majority boost 10 Gy ( 1 - 20 Gy ) after 50 Gy whole breast .", "label": "", "metadata": {}, "score": "68.41639"}
{"text": "Retrospective analysis .1569/1799 patients analyzed , 692 ( 44 % ) received optional boost .Majority boost 10 Gy ( 1 - 20 Gy ) after 50 Gy whole breast .", "label": "", "metadata": {}, "score": "68.41639"}
{"text": "Outcome : Conformality ratio for photon / proton plan 3.1 vs. photons only 5.7 for CTV1 , no difference for CTV2 .Normal tissues favored photon / proton plan .", "label": "", "metadata": {}, "score": "68.431564"}
{"text": "( Childs SK , Int J Radiat Oncol Biol Phys .2012 Sep 10 . )Retrospective .142 pts underwent mastectomy without RT for pure DCIS ( without microinvasion ) .", "label": "", "metadata": {}, "score": "68.433945"}
{"text": "( Allred DC , Online before print -- JCO March 5 , 2012 ) .Retrospectively measured ER and PR in 732 pts ( 41 % ) at central lab and determined receptor status for an additional 283 pts ( 16 % ) at local institutions .", "label": "", "metadata": {}, "score": "68.472946"}
{"text": "Silverstein MJ et al ( and Lewinsky BS ) .Cancer .1996 Jun 1;77(11):2267 - 74 .Came up with Van Nuys Prognostic Index ( VNPI ) .", "label": "", "metadata": {}, "score": "68.47511"}
{"text": "No difference with concurrent chemo .Conclusion : Concurrent chemo - RT superior for low - risk patients , but inadequate for high - risk patients .", "label": "", "metadata": {}, "score": "68.49996"}
{"text": "2004 Sep 1;60(1):156 - 64 . )Original ( AJCC 1992 ) stage : Stage III 20 % , Stage IV 80 % .Restaged ( AJCC 1997 ) : Stage II / III 71 % , Stage IV 29 % .", "label": "", "metadata": {}, "score": "68.558784"}
{"text": "In 2006/2007 we reevaluated our institutional policy for IMRT treatment of OCC patients .Having started IMRT treatments in 2002 , we could draw upon own experience and patient results as well as a small number of publications [ 7 - 13 ] .", "label": "", "metadata": {}, "score": "68.64455"}
{"text": "Conclusion : Long - term prognosis remains excellent , invasive IBTR increases risk for BCA - related death .EBCTCG DCIS ; 2010 PMID 20956824 -- \" Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast . \"", "label": "", "metadata": {}, "score": "68.684784"}
{"text": "Group 1 ( T1 - 2N0 - 1 , was entirely IIB ) vs. Group 2 ( T1 - 2N2 - 3 ) vs. Group 3 ( T3 - 4N0 - 1 ) vs. Group 4 ( T3 - 4N2 - 3 ) .", "label": "", "metadata": {}, "score": "68.701225"}
{"text": "The prescription range for dissected lymph node levels containing metastatic nodes is 60 - 66 Gy in the presence of ECE and 54 - 60 Gy without ECE , elective ( low neck and contralateral ) lymph node levels are prescribed 46.8 to 56 Gy .", "label": "", "metadata": {}, "score": "68.75789"}
{"text": "Angiographic results were evaluated with the modified Raymond grading system , whereas clinical outcomes were evaluated with the mRS scale .RESULTS : Seventeen ( 52 % ) aneurysms were classified as clinoid segment aneurysms , and 16 ( 48 % ) , as ophthalmic segment aneurysms .", "label": "", "metadata": {}, "score": "68.795715"}
{"text": "Retrospective .Median F / U 5 years .Of the 6 patients with LR , 5 had G3 DCIS and/or comedonecrosis .Swedish Cancer Institute , Seattle ; 2007 ( 1990 - 2006 ) ASTRO Abstract -- \" The Role of Adjuvant Radiotherapy After Mastectomy in Ductal Carcinoma In Situ , Breast \" ( Eulau SM , Abstract 2043 , 2007 ) .", "label": "", "metadata": {}, "score": "68.86859"}
{"text": "Primary endpoint OS and PFS .2006 PMID 16868539 -- \" Adjuvant chemotherapy vs radiotherapy in high - risk endometrial carcinoma : results of a randomised trial . \"", "label": "", "metadata": {}, "score": "68.99765"}
{"text": "Conclusion : Preliminary , significant benefit for tumor control at the cost of higher toxicity .No early OS benefit .Singapore SQNP01 ( 1997 - 2003 ) .", "label": "", "metadata": {}, "score": "69.002495"}
{"text": "No benefit of tamoxifen differs from B-24 trial : authors suggest it may be due to differences in the patient population .In B-24 33.5 % of patients were under 50 compared to only 9.5 % in the UK / ANZ trial .", "label": "", "metadata": {}, "score": "69.08206"}
{"text": "No benefit of tamoxifen differs from B-24 trial : authors suggest it may be due to differences in the patient population .In B-24 33.5 % of patients were under 50 compared to only 9.5 % in the UK / ANZ trial .", "label": "", "metadata": {}, "score": "69.08206"}
{"text": "MVA : Moderate / marked comedo necrosis and uncertain / positive margins predictive of IBT recurrence .12-years ; 2005 PMID 15752884 -- \" Cost - effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast . \"", "label": "", "metadata": {}, "score": "69.11595"}
{"text": "PubMed View Article .Chao KS , Ozyigit G , Tran BN , Cengiz M , Dempsey JF , Low DA : Patterns of failure in patients receiving definitive and postoperative IMRT for head - and - neck cancer .", "label": "", "metadata": {}, "score": "69.13783"}
{"text": "Epub 2015 Apr 15 . )Retrospective .33 patients from 2 institutions , Stage I - II carcinosarcoma .( 15 and 18 respectively ) .", "label": "", "metadata": {}, "score": "69.19234"}
{"text": "( Chua DT , Int J Radiat Oncol Biol Phys .2006 Aug 1;65(5):1300 - 6 .Epub 2006 Jun 5 . )Subset analysis .", "label": "", "metadata": {}, "score": "69.220184"}
{"text": "The GOG 99 trial randomized patients with Stage IB - IC or occult IIA - IIB ( selective LND ) to + /- EBRT .There was local control benefit , but no survival benefit .", "label": "", "metadata": {}, "score": "69.22067"}
{"text": "80 % had at least PLND .Arm 1 ) Pelvic EBRT split course 56 Gy ( 28 Gy x2 with 3 week break ) vs. Arm 2 ) Interdigitated chemo - RT , given as chemo - RT 28 Gy - chemo - RT 28 Gy - chemo .", "label": "", "metadata": {}, "score": "69.39313"}
{"text": "Buettner F , Miah AB , Gulliford SL , Hall E , Harrington KJ , Webb S , Partridge M , Nutting CM : Novel approaches to improve the therapeutic index of head and neck radiotherapy : An analysis of data from the PARSPORT randomised phase III trial .", "label": "", "metadata": {}, "score": "69.41904"}
{"text": "Conclusion : Concurrent chemo - RT well tolerated , but no benefit .5-years ; 2005 PMID 15812080 -- \" Overall survival after concurrent cisplatin - radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma . \"", "label": "", "metadata": {}, "score": "69.53746"}
{"text": "Nurses ' Health Study , 2005 - PMID 15770688 - \" Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy : results from the Nurses ' Health Study . \"", "label": "", "metadata": {}, "score": "69.61592"}
{"text": "Median age 60 ; median tumor sizes 6 mm ( low / int grade ) and 5 mm ( high grade ) .5-yr ipsilateral breast events 6.1 % ( low / int ) and 15.3 % ( high ) ; 7-yr rate 10.5 % ( low / int ) and 18.0 % ( high ) .", "label": "", "metadata": {}, "score": "69.766846"}
{"text": "( Hui EP , J Clin Oncol .2009 Jan 10;27(2):242 - 9 .Epub 2008 Dec 8 . )Randomized Phase II .65 patients , Stage III - IVB NPC .", "label": "", "metadata": {}, "score": "69.77411"}
{"text": "Further improvement of high - risk CTV definition might generally transfer into better LRRFS .Declarations .Acknowledgements .This work was presented at the 31st", "label": "", "metadata": {}, "score": "69.79038"}
{"text": "Methods .Patients .Between October 2003 and June 2008 we consecutively enrolled 50 patients with BTCs who underwent curative resection at Seoul National University Hospital and obtained a 18 F - FDG PET / CT for assessment of recurrence due based on clinical suspicion .", "label": "", "metadata": {}, "score": "69.925766"}
{"text": "( Rakovitch E , Int J Radiat Oncol Biol Phys .2013 Jul 1;86(3):491 - 7 . doi : 10.1016/j.ijrobp.2013.02.031 . )Retrospective .", "label": "", "metadata": {}, "score": "69.954704"}
{"text": "10-years , 2005 PMID 15927414 -- \" Postoperative radiotherapy for Stage 1 endometrial carcinoma : long - term outcome of the randomized PORTEC trial with central pathology review . \"", "label": "", "metadata": {}, "score": "69.97533"}
{"text": "1701 women with DCIS .2x2 factorial ( 921 randomized to fully 2x2 , the remaineder one way randomization to + /- RT or + /- TAM ) : BCS followed by 1 ) observation , 2 ) RT alone , 3 ) tamoxifen alone , or 4 ) RT + Tamoxifen .", "label": "", "metadata": {}, "score": "69.98447"}
{"text": "Toxicities were graded according to the National Cancer Institute ( NCI ) Common Terminology Criteria for adverse events ( CTCAE ) version 3.0 .The symptoms pain , dermatitis , mucositis , dysphagia , xerostomia and osteonecrosis were assessed .", "label": "", "metadata": {}, "score": "70.02011"}
{"text": "Conclusion : Selenium supplementation effective in improving blood selenium status in deficient patients , and reduces RT - induced diarrhea PMID : 22173755 Owner : NLM Status : Publisher .", "label": "", "metadata": {}, "score": "70.143036"}
{"text": "Conclusion : Radiation boost not associated with lower risk of local or invasive recurrence .McGill ; 2012 ( 2000 - 2006 ) PMID 21664063 -- \" Ductal carcinoma in situ -- the influence of the radiotherapy boost on local control . \"", "label": "", "metadata": {}, "score": "70.143845"}
{"text": "Median age 63 , Stage I disease 74 % , endometrioid 71 % , serous 15 % , clear cell 5 % , PLND 89 % .", "label": "", "metadata": {}, "score": "70.20979"}
{"text": "There was local control overall , but survival benefit only for Stage IC G3 .The PORTEC trial randomized patients with intermediate - risk Stage I ( specifically no IC G3 ; no lymph node dissection ) to + /- EBRT .", "label": "", "metadata": {}, "score": "70.23454"}
{"text": "Used classification below for cohort study : .2009 PMID 19784089 -- \" NIH state - of - the - science conference statement : diagnosis and management of ductal carcinoma in situ ( DCIS ) . \"", "label": "", "metadata": {}, "score": "70.243805"}
{"text": "Subgroup characteristics : boost group more likely to have SM+ 46 % vs. 37 % ( SS ) , or comedo necrosis 42 % vs. 35 % ( SS ) .", "label": "", "metadata": {}, "score": "70.32972"}
{"text": "When discussing a tumor recurrence in the ipsilateral breast , it is important to note the difference between a true recurrence and the development of a second primary in the irradiated breast .", "label": "", "metadata": {}, "score": "70.336945"}
{"text": "( Ma J , J Clin Oncol .2001 Mar 1;19(5):1350 - 7 . )Conclusion : No survival benefit for induction chemotherapy .Hokkaido RTOG ( 1991 - 1998 ) -- cisplatin , 5-FU .", "label": "", "metadata": {}, "score": "70.38671"}
{"text": "However , an additional PET / CT on ceCT significantly improved the sensitivity than did a ceCT alone ( 94 % [ 32/34 ] for PET / CT on ceCT vs .", "label": "", "metadata": {}, "score": "70.465"}
{"text": "Randomized .PORTEC 2 ( 2002 - 2006 ) -- Pelvic EBRT 46/23 vs. vaginal BT 21/3 .Randomized .427 patients , intermediate - high risk endometrial CA .", "label": "", "metadata": {}, "score": "70.47223"}
{"text": "PVAc / C60 adducts prepared with low [ PVAc]:[C60 ] ratios may contain weak C60-C60 bonds that further dissociate and account for the instability of the products .", "label": "", "metadata": {}, "score": "70.50986"}
{"text": "PubMed View Article .Tan HK , Giger R , Auperin A , Bourhis J , Janot F , Temam S : Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas - stratification for postsalvage survival .", "label": "", "metadata": {}, "score": "70.52836"}
{"text": "6 yr f / u but 10 yr results .Princess Margaret ; 2010 ( 1999 - 2004 ) PMID 20400190 -- \" Local control with conventional and hypofractionated adjuvant radiotherapy after breast - conserving surgery for ductal carcinoma in - situ . \"", "label": "", "metadata": {}, "score": "70.55783"}
{"text": "Acute toxicity grades of 2 ( 27 % ) and 3 ( 66 % ) and late toxicity grades of 2 ( 34 % ) and 3 ( 11 % ) were observed .", "label": "", "metadata": {}, "score": "70.5721"}
{"text": "Several Phase II trials have reported encouraging results in patients with significant N disease .Meta - analysis ; 2006 PMID 16377415 -- \" Chemotherapy in locally advanced nasopharyngeal carcinoma : an individual patient data meta - analysis of eight randomized trials and 1753 patients . \"", "label": "", "metadata": {}, "score": "70.67618"}
{"text": "Deep margin ( close 14 , positive 6 ) .Superficial margin ( close 13 , positive 19 ) .Median f / u 7.6 yr .", "label": "", "metadata": {}, "score": "70.68189"}
{"text": "When late toxicity was assessed at the last follow - up visit , the rates were below the pre - RT morbidity symptoms .This could be partly due to increased pain medication , use of gastrostomy tubes and other medical interventions as well as full recovery from surgery .", "label": "", "metadata": {}, "score": "70.71855"}
{"text": "RT use requires careful consideration , since no survival benefit .Comment : Reporting done differently between the 2 arms , special form for acute RT toxicity .", "label": "", "metadata": {}, "score": "70.72528"}
{"text": "As a result , induction chemotherapy is currently not indicated .Adjuvant chemotherapy was evaluated in 3 randomized trials ; there was no benefit .Phase II RTOG 81 - 17 demonstrated the feasibility of concurrent cisplatin with RT in advanced H&N cancers ; it included 22 % NPC .", "label": "", "metadata": {}, "score": "70.77402"}
{"text": "[ 1 ] Several other randomized studies demonstrated equivalent long - term survival and disease - free survival rates in patients treated by BCT compared to mastectomy .", "label": "", "metadata": {}, "score": "71.0146"}
{"text": "Excluded papillary serous and clear cell .Arm 1 ) EBRT 46/23 vs. Arm 2 ) HDR 21/3 or LDR 30/1 .Primary endpoint vaginal relapse .", "label": "", "metadata": {}, "score": "71.059044"}
{"text": "Therefore , if both image modalities are discordant , 18 F - FDG PET / CT is worthy of being weighted .Further prospective studies are necessary to establish the role of 18 F - FDG PET / CT during surveillance .", "label": "", "metadata": {}, "score": "71.170235"}
{"text": "15-year incidence of invasive IBTR for lumpectomy 19 % , lumpectomy + RT ( B-17 ) 8.9 % , lumpectomy + RT ( B-24 ) 10 % , lumpectomy + RT + TAM ( B-24 ) 8.5 % .", "label": "", "metadata": {}, "score": "71.188774"}
{"text": "PubMed View Article .Bartlett RRDL , Ben - Josef E : Cancer of the Biliary Tree .In DeVita J , VT , Lawrence TS , Rosenberg SA , eds Cancer : Principles & Practive of Oncology .", "label": "", "metadata": {}, "score": "71.20181"}
{"text": "Outcome : IBTR SM- 13 % vs. SM+ 23 % ( SS ) .By margin status , if SM- boost 13 % vs no boost 13 % ( NS ) , if SM+ boost 21 % vs. no boost 26 % ( NS ) .", "label": "", "metadata": {}, "score": "71.23428"}
{"text": "( Cooper JS et al .Int J Radiat Oncol Biol Phys . 2000 Jul 1;47(4):861 - 6 . )Retrospective single institution .Repeated regimen of Intergroup 0099 .", "label": "", "metadata": {}, "score": "71.363945"}
{"text": "PubMed View Article .Kim JY , Kim MH , Lee TY , Hwang CY , Kim JS , Yun SC , Lee SS , Seo DW , Lee SK : Clinical role of 18F - FDG PET - CT in suspected and potentially operable cholangiocarcinoma : a prospective study compared with conventional imaging .", "label": "", "metadata": {}, "score": "71.44456"}
{"text": "Closed due to poor accrual .Arm 1 ) RT vs. Arm 2 ) no RT .Radiotherapy to the whole breast consists of a choice of 50.4 Gy in 1.8 Gy fractions , 50 Gy in 2 Gy , or 42.5 Gy in 16 fx .", "label": "", "metadata": {}, "score": "71.45202"}
{"text": "The spinal cord constraints appear to be reasonable , however , late sacral nerve toxicity after 77.4 Gy is seen but is uncommon .Scientific / Clinical Implications .", "label": "", "metadata": {}, "score": "71.476944"}
{"text": "Randomized .601 patients , Stage I endometrial with high risk features , Stage II endometrial , Stage I - II serous or clear cell .", "label": "", "metadata": {}, "score": "71.48259"}
{"text": "Doses were reduced for radiosensitive histologies , concurrent chemoradiation , or when diabetes or autoimmune disease were present .If radiation was used pre - operatively a dose of 30.6 Gy was used except in the sacrum where 19.8 Gy was used .", "label": "", "metadata": {}, "score": "71.68007"}
{"text": "2010 Update ( -2009 ) PMID 20956828 -- \" Choosing treatment for patients with ductal carcinoma in situ : fine tuning the University of Southern California / Van Nuys Prognostic Index . \"", "label": "", "metadata": {}, "score": "71.70285"}
{"text": "We have now retrospectively analyzed the outcome and patterns of failure of patients at our center having been treated accordingly .Methods .Patient selection .", "label": "", "metadata": {}, "score": "71.74089"}
{"text": "In case of reported intraoperative spillage ( tumor and / or metastatic lymph node rupture ) the whole corresponding surgically manipulated area was defined as CTV60 - 66 , e.g. the complete area of neck dissection [ 15 ] . CTV54 included the CTV72 or CTV60 - 66 plus dissected lymph node levels with 1 ( pN1 ) or more metastatic lymph nodes ( pN2b , pN2c ) without ECE and the elective contralateral not dissected neck levels in case of unilateral neck dissection and was treated to 54 Gy .", "label": "", "metadata": {}, "score": "71.85615"}
{"text": "Toxicity : No lymphedema , decreased shoulder ROM 12 % , chronic mild pain 12 % .In 2 immediate reconstructions , both failed .In 2 delayed reconstruction , neither failed .", "label": "", "metadata": {}, "score": "71.94324"}
{"text": "Conclusion : Concurrent chemo - RT superior to RT alone for advanced NPC .Re - analysis ; 2004 PMID 15337551 -- \" Another way to estimate outcome of advanced nasopharyngeal carcinoma -- is concurrent chemoradiotherapy adequate ? \"", "label": "", "metadata": {}, "score": "71.944916"}
{"text": "5-years ; 2003 PMID 12867108 -- \" Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK , Australia , and New Zealand : randomised controlled trial . \"", "label": "", "metadata": {}, "score": "71.95707"}
{"text": "5-years ; 2003 PMID 12867108 -- \" Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK , Australia , and New Zealand : randomised controlled trial . \"", "label": "", "metadata": {}, "score": "71.95707"}
{"text": "2009 Jan 10;373(9658):125 - 36 .Epub 2008 Dec 16 . )Comment ; 2010 PMID 19897230 -- \" ASTEC lymphadenectomy and radiation therapy studies : are conclusions valid ? \"", "label": "", "metadata": {}, "score": "72.07033"}
{"text": "The following abbreviations are used in this paper .BTC : . biliary tract cancer .ceCT : . contrast - enhanced computed tomography .18 F - FDG PET / CT : . 18 F - fluorodeoxyglucose positron emission tomography integrated with computed tomography .", "label": "", "metadata": {}, "score": "72.07764"}
{"text": "Journal Rad .Biol .Physics by Dr. DeLaney in 2009 .This is a report of the long - term data .Methods .Eligible patients had nonmetastatic , thoracic , lumbar , and/or sacral spine / paraspinal sarcomas .", "label": "", "metadata": {}, "score": "72.2124"}
{"text": "PubMed View Article .Petrowsky H , Wildbrett P , Husarik DB , Hany TF , Tam S , Jochum W , Clavien PA : Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma .", "label": "", "metadata": {}, "score": "72.24443"}
{"text": "4 year mets - free rate : 98 % vs. 99 % .Contralateral breast cancer 99 % lumpectomy alone and 97 % with RT ( SS ) .", "label": "", "metadata": {}, "score": "72.394"}
{"text": "Despite this limitation it appears that LRRFS after postoperative IMRT is promising with acceptable acute and late toxicity rates .Conclusion .Postoperative IMRT of locally advanced or high - risk OCC was associated with satisfying LRRFS .", "label": "", "metadata": {}, "score": "72.541565"}
{"text": "PMID 16434629 -- \" Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma . \"( Lee CM , JAMA .", "label": "", "metadata": {}, "score": "72.67384"}
{"text": "MRC ASTEC and NCIC CTG EN.5 ( 1996 - 2005 ) -- EBRT vs Observation .Two randomized trials merged in 1998 to pool results and facilitate data monitoring .", "label": "", "metadata": {}, "score": "72.70442"}
{"text": "2009 Sep 24;26(2):1 - 27 . )Reviews .Breast - conservation therapy ( BCT ) , consisting of lumpectomy followed by whole - breast irradiation ( WBI ) , is the standard of care for women with early - stage breast cancer .", "label": "", "metadata": {}, "score": "72.73054"}
{"text": "Toxicity : Acute Grade 4 mucositis 4 % ; Late Grade 3 dysphagia 5 % , xerostomia 3 % .Long - term PEG - dependent 4 % .", "label": "", "metadata": {}, "score": "72.830124"}
{"text": "2010 PMID 20206777 -- \" Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high - intermediate risk ( PORTEC-2 ) : an open - label , non - inferiority , randomised trial . \"", "label": "", "metadata": {}, "score": "72.86228"}
{"text": "Incremental cost - effectiveness rate ( ICER ) : $ 36,700 per QALY .Conclusion : should not withold RT because of cost - effectiveness .", "label": "", "metadata": {}, "score": "72.89665"}
{"text": "Conclusion : EBRT alone not indicated due to no benefit on OS / DFS , but higher toxicity .RT ; 2009 PMID 19070891 -- \" Adjuvant external beam radiotherapy in the treatment of endometrial cancer ( MRC ASTEC and NCIC CTG EN.5 randomised trials ) : pooled trial results , systematic review , and meta - analysis . \"", "label": "", "metadata": {}, "score": "72.9995"}
{"text": "This study used a mixed beam approach for several reasons : 1 ) skin sparing with photons and 2 ) decreased time on the proton therapy gantry permitting a greater total number of patients to be treated .", "label": "", "metadata": {}, "score": "73.19142"}
{"text": "The posterior rectal wall was allowed to receive full radiation dose .Small bowel maximum dose of 50.4 Gy ( MGH currently allows 57.6 Gy to 50 % up to 10 cm ) .", "label": "", "metadata": {}, "score": "73.25118"}
{"text": "Concurrent RT 66 - 73.8 Gy with cisplatin 100 mg / m2 q3 weeks .60 % completed planned treatment .Overall ; 1987 PMID 3802013 -- \" Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck .", "label": "", "metadata": {}, "score": "73.27609"}
{"text": "Toxicity Grade 3 - 4 : stomatitis 29 % vs. 19 % , nausea 14 % vs. 5 % , leukopenia 23 % vs. 1 % .", "label": "", "metadata": {}, "score": "73.326385"}
{"text": "Results .Patients .Fifty patients were enrolled .The patient characteristics are shown in Table 1 .The locations of tumors were as follows : intrahepatic , 24 % ; common bile duct , 40 % ; ampullar of Vater , 28 % and gallbladder , 8 % .", "label": "", "metadata": {}, "score": "73.35513"}
{"text": "However , our data did not show that the SUV max was the significant prognostic factor for overall survival , probably due to the low number of patients and selection bias .", "label": "", "metadata": {}, "score": "73.54605"}
{"text": "In the upper sacrum , several patients had biopsy only .If plaque therapy was give , 90 Ytrium was used , delivered as 10 Gy for lesions abutting spinal cord .", "label": "", "metadata": {}, "score": "73.67755"}
{"text": "Sites within the spine were as follows : thoracic 11 lumbar 13 , sacrum 26 .Primary tumors were treated in 36 and locally recurrent tumors in 14 patients .", "label": "", "metadata": {}, "score": "73.68638"}
{"text": "Surgery 2002 , 132 ( 4 ) : 555 - 563 . discission 563 - 554 PubMed View Article .Hezel AF , Zhu AX : Systemic therapy for biliary tract cancers .", "label": "", "metadata": {}, "score": "73.688614"}
{"text": "Brachytherapy boost .Long Beach Memorial Hospital ; 2000 ( 1978 - 97 ) PMID 10889385 -- \" Brachytherapy for primary and recurrent nasopharyngeal carcinoma : 20 years ' experience at Long Beach Memorial . \"", "label": "", "metadata": {}, "score": "73.72996"}
{"text": "However , the mean SUV max by each recurrent site was similar ( 4.53 in locoregional areas , 4.4 in lymph node areas ) .Among 34 patients with recurrent disease , we calculated the median value of SUV max ( 3.35 ) and compared overall survival between patients with SUV max of 3.35 or less and greater than 3.35 .", "label": "", "metadata": {}, "score": "73.84913"}
{"text": "Collectively , these data suggest that for older women , although radiation may be safely avoided , it is rational for elderly women with long life expectancies and low comorbidities to receive radiotherapy after lumpectomy , given its benefit .", "label": "", "metadata": {}, "score": "73.94907"}
{"text": "This treatment is extremely well tolerated with minimal long - term complications and favorable cosmetic outcomes .[15,16 ] Despite the obvious cosmetic and potential psychosocial advantages of BCS+RT , 15 % to 30 % of patients who undergo lumpectomy do not receive postoperative radiotherapy .", "label": "", "metadata": {}, "score": "73.99623"}
{"text": "Cochrane meta - analysis did n't find benefit for EBRT in IA - ICG2 , but found 10 % survival benefit in ICG3 .SEER Registry population - based analysis revealed statistically significant benefit for survival with adjuvant radiation in Stage IC patients , but not IA - B .", "label": "", "metadata": {}, "score": "74.00551"}
{"text": "Radiother Oncol 2006 , 79 : 15 - 20 .PubMed View Article .Eisbruch A , Foote RL , O'Sullivan B , Beitler JJ , Vikram B : Intensity - modulated radiation therapy for head and neck cancer : emphasis on the selection and delineation of the targets .", "label": "", "metadata": {}, "score": "74.01516"}
{"text": "2008 PMID 18250350 -- \" Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast . \"", "label": "", "metadata": {}, "score": "74.036285"}
{"text": "Studies .RAND Corporation ; 2011 ( 1985 - 2000 ) PMID 21200025 -- \" Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons . \"", "label": "", "metadata": {}, "score": "74.14973"}
{"text": "PLND not required ; women with positive pelvic LN eligible for ASTEC but not EN.5 .Para - aortic LN+ excluded .Peritoneal washings could be negative , positive , or not done .", "label": "", "metadata": {}, "score": "74.20728"}
{"text": "The data were analyzed in SPSS ( SPSS Inc. , Chicago , IL , version 19.0 ) and SAS ( Statistical Analysis Systems Institute Inc , version 9.2 ) .", "label": "", "metadata": {}, "score": "74.366875"}
{"text": "Pre - RT morbidity and acute and late toxicity .After surgery and prior to RT , pre - RT morbidity was determined ( Table 4 ) .", "label": "", "metadata": {}, "score": "74.37973"}
{"text": "Trial not really powered to show survival difference .15 years , 2011 -- Outcome and QOL PMID 21444867 -- \" Long - Term Outcome and Quality of Life of Patients With Endometrial Carcinoma Treated With or Without Pelvic Radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 ( PORTEC-1 ) Trial . \"", "label": "", "metadata": {}, "score": "74.48561"}
{"text": "J Nucl Med 2007 , 48 ( 8) : 1251 - 1258 .PubMed View Article .Furukawa H , Ikuma H , Asakura K , Uesaka K : Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose - positron emission tomography in biliary tract carcinoma .", "label": "", "metadata": {}, "score": "74.585495"}
{"text": "No brachytherapy .4-years , 2004 PMID 14984936 - \" A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma : a Gynecologic Oncology Group study . \"", "label": "", "metadata": {}, "score": "74.63571"}
{"text": "Biol .Physics 1995 ) .A prospective phase II trial evaluating high - dose photon / proton RT for spine sarcomas accrued patients between 1997 and 2005 .", "label": "", "metadata": {}, "score": "74.68304"}
{"text": "It was our policy to contour the resected tumor and all metastatic lymph nodes in their former location and full dimension in the planning CT if possible , using all available information ( clinical descriptions , all preoperative imaging modalities , surgical reports ) .", "label": "", "metadata": {}, "score": "74.72293"}
{"text": "Am J Clin Oncol .2002 Jun;25(3):219 - 23 . ) 6 trials , 1528 patients ( concurrent : INT 0099 ; induction : Hong Kong , Guangzhou , AOCOA , VUMCA ; adjuvant : Italian ) .", "label": "", "metadata": {}, "score": "74.74986"}
{"text": "AG , BB and PG collected the data and together with SC , AA , PM , WH and DMA interpreted the data .The manuscript was written by AG and PG , all other authors helped and finally approved the final manuscript .", "label": "", "metadata": {}, "score": "74.80621"}
{"text": "Also significant hematologic toxicity .Conclusion : Confirmation of INT 0099 results ; also applicable in endemic NPC .Queen Mary Hospital , Hong Kong ( 1995 - 2001 ) .", "label": "", "metadata": {}, "score": "74.88368"}
{"text": "Coiling was done with balloon assistance in 36 % of cases and stent - assistance in 6 % .Technical complications occurred in 1 patient , contributing to death .", "label": "", "metadata": {}, "score": "74.90927"}
{"text": "Gamez C , Rosell R , Fernandez A , Andia E , Arnaiz MD , Cardenal F , Lorenzo C : PET / CT fusion scan in lung cancer : current recommendations and innovations .", "label": "", "metadata": {}, "score": "74.92297"}
{"text": "The study protocol was reviewed and approved by the Institutional Review Board of Seoul National University Hospital ( IRB No : 1001 - 001 - 304 ) .", "label": "", "metadata": {}, "score": "75.02106"}
{"text": "Brachy given to 52 % patients in both arms .2007 ASCO Abstract -- \" Adjuvant external beam radiotherapy ( EBRT ) in the treatment of endometrial cancer : Results of the randomised MRC ASTEC and NCIC CTG EN.5 trial . \"", "label": "", "metadata": {}, "score": "75.12457"}
{"text": "Recently , 18 F - fluorodeoxyglucose positron emission tomography integrated with computed tomography ( 18 F - FDG PET / CT ) has been introduced and considered to be a valuable imaging tool by combining anatomic and metabolic imaging information in cancer [ 5 ] .", "label": "", "metadata": {}, "score": "75.17152"}
{"text": "\" J Clin Oncol 30 , 2012 ( suppl ; abstr 1004 ) ' -- RT vs. No RT \" 98 - 04 .636 randomized .", "label": "", "metadata": {}, "score": "75.33297"}
{"text": "All patients underwent resection of the primary tumor and an uni- or bilateral modified radical neck dissection in the Department of Otorhinolaryngology , Head and Neck Surgery and / or Department of Craniomaxillofacial Surgery , Inselspital Bern , University Hospital .", "label": "", "metadata": {}, "score": "75.38827"}
{"text": "All treatment plans were contoured and calculated by Eclipse treatment planning system ( Varian Medical Systems , Palo Alto , CA ) .Concomitant systemic therapy .", "label": "", "metadata": {}, "score": "75.432"}
{"text": "Taiwan ( 1993 - 1999 ) .Randomized .284 patients , NPC Stage III - IV M0 , histology WHO I ( 3 % ) , WHO II ( 73 % ) , WHO III ( 24 % ) .", "label": "", "metadata": {}, "score": "75.78662"}
{"text": "Brachytherapy not mentioned ( not given ? )2008 PMID 18534669 -- \" Surgically staged high - risk endometrial cancer : Randomized study of adjuvant radiotherapy alone vs. sequential chemo - radiotherapy . \"", "label": "", "metadata": {}, "score": "75.7916"}
{"text": "BT boost in only 6 patients ( 3 % ) .Arm 2 ) CAP ( cyclophosphamide ( 333 mg / m2 ) , doxorubicin ( 40 mg / m2 ) and cisplatin ( 50 mg / m2 ) x3 + courses .", "label": "", "metadata": {}, "score": "75.80707"}
{"text": "BT had slightly higher pelvic failure rate ( NS ) , but no impact on OS , and was felt to be the standard of care for these patients .", "label": "", "metadata": {}, "score": "75.82692"}
{"text": "Mayo Clinic / Harvard ; 2015 PMID 25890795 -- \" Vaginal brachytherapy for early - stage carcinosarcoma of the uterus . \"( Brown LC , Brachytherapy .", "label": "", "metadata": {}, "score": "75.942406"}
{"text": "Conclusion : EBRT for endometrial cancer is associated with long - term urinary and bowel symptoms and lower functioning . \"Despite its efficacy in reducing locoregional recurrence , EBRT should be avoided in patients with low- and intermediate - risk EC . \"", "label": "", "metadata": {}, "score": "75.94366"}
{"text": "Gynecol Oncol .2006 Oct;103(1):155 - 9 .Median f / u 4 yrs .Excellent local control .Tolerable regimen .Preliminary ; 2004 PMID 15093913 , 2004 - \" Preliminary analysis of RTOG 9708 : Adjuvant postoperative radiotherapy combined with cisplatin / paclitaxel chemotherapy after surgery for patients with high - risk endometrial cancer .", "label": "", "metadata": {}, "score": "76.00276"}
{"text": "Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter - phased radiofrequency energy : 2-year follow - up and predictors of failure .", "label": "", "metadata": {}, "score": "76.268074"}
{"text": "Prior to IMRT planning all patients were referred for dental evaluation and treatment if necessary .For treatment planning a dedicated high - resolution CT scan with 3 mm slices and intravenous contrast was used .", "label": "", "metadata": {}, "score": "76.353745"}
{"text": "In addition postoperative RT increased overall survival ( OS ) in nodal positive patients as compared to surgery alone [ 2 ] .Furthermore postoperative cisplatin based chemoradiation is known to increase time to locoregional recurrence as well as OS in patients with positive resection margins and lymph node metastasis with extracapsular extension ( ECE ) [ 3 ] .", "label": "", "metadata": {}, "score": "76.355034"}
{"text": "Conclusion : EBRT reduces LR but has no impact on survival .Side effects , 2001 PMID 11728684 -- \" The morbidity of treatment for patients with Stage I endometrial cancer : results from a randomized trial . \"", "label": "", "metadata": {}, "score": "76.522736"}
{"text": "Emory ; 2007 PMID 17481544 -- \" Local recurrence of ductal carcinoma in situ after skin - sparing mastectomy . \"( Carlson GW , J Am Coll Surg .", "label": "", "metadata": {}, "score": "76.67381"}
{"text": "Surgeon impact : If surgeon effect were improved to mean , IBTR reduction by 15 % ; if median , IBTR reduction by 22 % , and if at 75th percentile , IBTR reduction by 31 % .", "label": "", "metadata": {}, "score": "76.69008"}
{"text": "PubMed View Article .Lim HS , Yoon W , Chung TW , Kim JK , Park JG , Kang HK , Bom HS , Yoon JH : FDG PET / CT for the detection and evaluation of breast diseases : usefulness and limitations .", "label": "", "metadata": {}, "score": "76.754715"}
{"text": "2015 : 12 year PMID 26371148 -- \" Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast : 12-Year Results From the ECOG - ACRIN E5194 Study . \"", "label": "", "metadata": {}, "score": "76.85681"}
{"text": "Quality of life better , so should be considered standard for these patients .QoL ; 2009 PMID 19546404 -- \" Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer : first results of the randomized PORTEC-2 trial . \"", "label": "", "metadata": {}, "score": "77.06146"}
{"text": "Toxicity : No difference .Conclusion : Adjuvant chemo useful alternative , especially in higher risk patients .GOG 156 .Randomized .Stage IB - IIB .", "label": "", "metadata": {}, "score": "77.16433"}
{"text": "Advocates of APBI state that it is a safe , well tolerated therapy that allows for equivalent cosmetic outcomes while significantly increasing quality of life and allowing for an effective treatment of the patient 's breast cancer .", "label": "", "metadata": {}, "score": "77.31499"}
{"text": "Final ; 2006 PMID 16545437 , 2006 - \" Final analysis of RTOG 9708 : adjuvant postoperative irradiation combined with cisplatin / paclitaxel chemotherapy following surgery for patients with high - risk endometrial cancer .", "label": "", "metadata": {}, "score": "77.54967"}
{"text": "Closed due to nonaccrual .Italy ( 1990 - 1997 ) -- adjuvant EBRT vs. cisplatin / doxorubicin / cyclophosphamide .Randomized .345 patients .", "label": "", "metadata": {}, "score": "77.65149"}
{"text": "Wolters Kluwer ; Lippincott Williams & Wilkins ; 2008:1156 - 1186 .Benson AB , Abrams TA , Ben - Josef E , Bloomston PM , Botha JF , Clary BM , Covey A , Curley SA , D'Angelica MI , Davila R , et al .", "label": "", "metadata": {}, "score": "78.03375"}
{"text": "PubMed View Article .Gomez DR , Zhung JE , Gomez J , Chan K , Wu AJ , Wolden SL , Pfister DG , Shaha A , Shah JP , Kraus DH , Wong RJ , Lee NY : Intensity - modulated radiotherapy in postoperative treatment of oral cavity cancers .", "label": "", "metadata": {}, "score": "78.15141"}
{"text": "They compared those women over age 70 treated with radiotherapy following lumpectomy to those treated by lumpectomy alone .In this nonrandomized study , they found that radiotherapy not only reduced local recurrence but also reduced the rate of any second breast cancer event and subsequent mastectomy .", "label": "", "metadata": {}, "score": "78.17224"}
{"text": "The following normal tissue constraints were used : .Spine : 63 Gy to the surface and 54 Gy to the center for up to 5 cm in superior - inferior length .", "label": "", "metadata": {}, "score": "78.551094"}
{"text": "PubMed View Article .Therasse P , Arbuck SG , Eisenhauer EA , Wanders J , Kaplan RS , Rubinstein L , Verweij J , Van Glabbeke M , van Oosterom AT , Christian MC , et al .", "label": "", "metadata": {}, "score": "78.85771"}
{"text": "PLND optional .Pelvic RT 44 Gy ( vaginal BT optional , given in 41 % ) + /- 4 cycles of chemo ( several regimens allowed ) .", "label": "", "metadata": {}, "score": "78.96354"}
{"text": "Anton A W Mulder Department of Cardiology , St Antonius Hospital , Nieuwegein , The Netherlands Europace 13:1695 - 702 .We evaluated the long - term effects of a novel approach for ablation of persistent AF using multi - electrode catheters ... .", "label": "", "metadata": {}, "score": "78.96677"}
{"text": "Anton A W Mulder Department of Cardiology , St Antonius Hospital , Nieuwegein , EM , The Netherlands Europace 13:1557 - 61 .We evaluated the effect of pulmonary vein ( PV ) anatomical characteristics on PV isolation ( PVI ) and long - term efficacy of ablation with phased radiofrequency ( RF ) energy and pulmonary vein ablation catheter ( PVAC ) multi - electrode catheter ...", "label": "", "metadata": {}, "score": "78.98448"}
{"text": "Extent of surgeon variation and its contribution to long - term outcomes are troubling .Memorial Sloan Kettering ; 2010 ( 1991 - 1995 ) PMID 20224381 -- \" The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast - conserving therapy . \"", "label": "", "metadata": {}, "score": "79.1642"}
{"text": "PubMed .Kwee TC , Kwee RM , Nievelstein RA : Imaging in staging of malignant lymphoma : a systematic review .Blood 2008 , 111 ( 2 ) : 504 - 516 .", "label": "", "metadata": {}, "score": "79.255646"}
{"text": "PMID 16750316 -- \" Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast . \"( Smith GL , Int J Radiat Oncol Biol Phys .", "label": "", "metadata": {}, "score": "79.315285"}
{"text": "Conclusion : Chemo - RT in NPC effective , should be evaluated in phase III .Beijing Hospital , China ( 2001 - 2003 ) -- RT + /- recombinant adenovirus - p53 .", "label": "", "metadata": {}, "score": "79.346466"}
{"text": "( Silverstein MJ , Oncology ( Williston Park ) .2003 Nov;17(11):1511 - 33 ; discussion 1533 - 4 , 1539 , 1542 passim . ) 1999 Subsequent report on margins : PMID 10320383 Full text , 1999 ( 1979 - 1998 ) - \" The influence of margin width on local control of ductal carcinoma in situ of the breast . \"", "label": "", "metadata": {}, "score": "79.63875"}
{"text": "PubMed View Article .Daly ME , Lee QT , Kozak MM , Maxim PG , Murphy JD , Hsu A , Loo BW Jr , Kaplan MJ , Fischbein NJ , Chang DT : Intensity - modulated radiotherapy for oral cavity squamous cell carcinoma : patterns of failure and predictors of local control .", "label": "", "metadata": {}, "score": "79.651245"}
{"text": "RTOG 81 - 17 ( 1981 - 1984 ) .Phase II .124 patients , locally advanced inoperable H&N cancer ( oropharynx 39 % , nasopharynx 22 % , oral cavity 18 % , hypopharynx 7 % , larynx 7 % , sinuses 7 % ) .", "label": "", "metadata": {}, "score": "79.87356"}
{"text": "Arrhythmia detection after atrial fibrillation ablation : value of incremental monitoring time .Anton A W Mulder Department of Cardiology , St Antonius Hospital , Nieuwegein , The Netherlands Pacing Clin Electrophysiol 35:164 - 9 .", "label": "", "metadata": {}, "score": "80.13318"}
{"text": "Randomized , 2x2 design ( concurrent chemo vs. none , adjuvant chemo vs. none ) .Arm 1 ) RT alone vs. Arm 2 ) concurrent chemo - RT vs. Arm 3 ) RT + adjuvant chemo vs. Arm 4 ) concurrent chemo - RT + adjuvant RT .", "label": "", "metadata": {}, "score": "80.157974"}
{"text": "J Natl Compr Canc Netw 2009 , 7 ( 4 ) : 350 - 391 .PubMed .Juweid ME , Cheson BD : Positron - emission tomography and assessment of cancer therapy .", "label": "", "metadata": {}, "score": "80.33521"}
{"text": "Additional randomized studies comparing lumpectomy alone to lumpectomy and radiation clearly demonstrate a threefold reduction in local relapse with the use of radiation following breast - conserving surgery .", "label": "", "metadata": {}, "score": "80.35327"}
{"text": "Anton A W Mulder Department of Cardiology , St Antonius Hospital , Nieuwegein , The Netherlands Europace 13:1695 - 702 .Pulmonary vein anatomy and long - term outcome after multi - electrode pulmonary vein isolation with phased radiofrequency energy for paroxysmal atrial fibrillation .", "label": "", "metadata": {}, "score": "80.40848"}
{"text": "Holland et al reviewed 217 mastectomy specimens from patients in the Netherlands with tumors less than 4 cm .[34 ] .[ 35 ] The group found that 89 % of patients who met these criteria were correctly identified as having a true breast carcinoma of limited extent .", "label": "", "metadata": {}, "score": "80.40887"}
{"text": "Conclude : Tamoxifen of benefit for further reduction of invasive breast cancer recurrences .There was no difference in regional or distant metastases .Authors suggest that RT+tam concurrent is of benefit but a recent paper in JCO disputes this theory .", "label": "", "metadata": {}, "score": "80.41905"}
{"text": "Randomized .Arm 1 ) RT with concurrent cisplatin 40 mg / m2 q week vs. Arm 2 ) RT alone .RT 66 Gy , parapharyngeal boost 10 - 20 Gy allowed .", "label": "", "metadata": {}, "score": "80.429474"}
{"text": "Guangzhou ( 1993 - 1994 ) - cisplatin , 5-FU , bleomycin .Randomized .456 patients .Chinese stage III - IV M0 .", "label": "", "metadata": {}, "score": "80.46719"}
{"text": "SM- ( intraop evaluation of margins , re - excision if needed ) .Lumpectomy alone to lumpectomy + RT 50 Gy .( Bijker N , J Clin Oncol .", "label": "", "metadata": {}, "score": "80.49251"}
{"text": "[ 16 ] .All prescribed CTV - margins were anatomically adapted to account for natural barriers such as thyroid and cricoid cartilage , hyoid , mandibular or vertebral bone and for skin and air .", "label": "", "metadata": {}, "score": "80.77021"}
{"text": "Conclusion : Effect of RT on IBTR influenced by disease volume near margin .Institut Curie ; 2009 PMID 19386441 -- \" Ductal carcinoma in situ of the breast with close or focally involved margins following breast - conserving surgery : treatment with reexcision or radiotherapy with increased dosage . \"", "label": "", "metadata": {}, "score": "80.88957"}
{"text": "PubMed View Article .van der Laan HP , Christianen ME , Bijl HP , Schilstra C , Langendijk JA : The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction : An in silico planning comparative study .", "label": "", "metadata": {}, "score": "80.897026"}
{"text": "Dublin ; 2009 PMID 19255332 -- \" Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ . \"", "label": "", "metadata": {}, "score": "81.061874"}
{"text": "Yao M , Chang K , Funk GF , Lu H , Tan H , Wacha J , Dornfeld KJ , Buatti JM : The failure patterns of oral cavity squamous cell carcinoma after intensity - modulated radiotherapy : The University of Iowa experience .", "label": "", "metadata": {}, "score": "81.3165"}
{"text": "Accrual has been brisk and is expected to close earlier than expected .Abstract .Background .To determine the outcome and patterns of failure in oral cavity cancer ( OCC ) patients after postoperative intensity modulated radiotherapy ( IMRT ) with concomitant systemic therapy .", "label": "", "metadata": {}, "score": "81.68753"}
{"text": "The authors declare that they have no competing interests .Authors ' contributions .YGL contributed to the study design , data collection / analysis / interpretation and writing of the manuscript .", "label": "", "metadata": {}, "score": "81.69563"}
{"text": "Rationale .In standard BCS+RT , radiotherapy is delivered to the whole breast to eliminate areas of occult multicentric in situ or invasive carcinoma .Additional radiotherapy may be delivered to the tumor bed using a boost to eliminate the higher burden of microscopic disease that may have been left in close proximity to the tumor bed after lumpectomy .", "label": "", "metadata": {}, "score": "81.78815"}
{"text": "Use of ER ; 2002 ( No PMID ) \" Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS : findings from NSABP Protocol B-24 . \"", "label": "", "metadata": {}, "score": "81.88288"}
{"text": "2015 Nov 20;33(33):3938 - 44 . ) -- Median f / u 12.3 yr .12 yr rate of ipsilateral breast event ( IBE ) 14.4 % ( Cohort 1 ) and 24.6 % ( Cohort 2 ) .", "label": "", "metadata": {}, "score": "82.04645"}
{"text": "All scans were performed with one of two PET / CT systems ( Philips Gemini Dual ; Best , The Netherlands [ from October 2003 to the end of the study ] or SIMENS Biograph TruePoint ; Germany [ from November 2007 to the end of the study ] ) .", "label": "", "metadata": {}, "score": "82.1702"}
{"text": "The grafting mechanism of poly(vinyl acetate ) macroradicals prepared by cobalt - mediated radical polymerization onto C60 is investigated .The experimental conditions directly impact the nature and stability of the PVAc / C60 adducts .", "label": "", "metadata": {}, "score": "82.240486"}
{"text": "Greene FL , American Joint Committee on Cancer ., American Cancer Society : AJCC cancer staging manual .6th edition .New York : Springer - Verlag ; 2002 .", "label": "", "metadata": {}, "score": "82.52315"}
{"text": "Each author had participated sufficiently in the work to take public responsibility for appropriate portions of the content .AG , PG and DMA designed the study .", "label": "", "metadata": {}, "score": "82.54695"}
{"text": "PubMed View Article .Greene FL , Page DL , Fleming ID ( Eds ) : AJCC cancer staging manual .6th edition .Philadelphia : Springer ; 2002 .", "label": "", "metadata": {}, "score": "82.655075"}
{"text": "However , they were able to achieve the dose constraints outlined above .Alternative approaches to sarcoma radiation include hypofractionation including stereotactic radiotherapy .The concern with this approach is that large fraction sizes may cause late toxicity to nerve roots more than smaller fraction sizes .", "label": "", "metadata": {}, "score": "83.01649"}
{"text": "TAM 20 mg QD ( noncompliance 31 % ) .5-years ; 1999 PMID 10376613 -- \" Tamoxifen in treatment of intraductal breast cancer : National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial . \"", "label": "", "metadata": {}, "score": "83.124954"}
{"text": "PET / CT showed higher sensitivity and accuracy compared to ceCT , but the results did not reach statistical significance .In addition , the site - specific diagnostic efficacy did not show any significant difference between each diagnostic modality ( Table 5 ) .", "label": "", "metadata": {}, "score": "83.137665"}
{"text": "Locoregional control was 77 % at 5 years and 70 % at 8 years .Overall survival was 83 % at 5 years and 64 % at 8 years .", "label": "", "metadata": {}, "score": "83.21053"}
{"text": "Radiotherapy for spine sarcomas is constrained by the spinal cord , nerve , and viscera tolerance .The local failure rates of chordomas and chondrosarcomas of the spine are very high .", "label": "", "metadata": {}, "score": "83.23883"}
{"text": "PubMed View Article .Studer G , Zwahlen RA , Graetz KW , Davis BJ , Glanzmann C : IMRT in oral cavity cancer .Radiat Oncol 2007 , 2 : 16 .", "label": "", "metadata": {}, "score": "83.5433"}
{"text": "High grade also influenced LR .Conclusion : LR after skin - sparing mastectomy similar to total mastectomy .Re - excision of close SM should be performed and adjuvant RT should be considered .", "label": "", "metadata": {}, "score": "83.58504"}
{"text": "I Loumiotis ; P I D'Urso ; R Tawk ; H J Cloft ; D F Kallmes ; V Kairouz ; R Hanel ; G Lanzino .", "label": "", "metadata": {}, "score": "84.70979"}
{"text": "evaluated the prognostic significance of FDG uptake on PET in patients with biliary tract cancer and demonstrated the SUV max of 6.3 to be the optimal cutoff point for survival [ 21 ] .", "label": "", "metadata": {}, "score": "84.81296"}
{"text": "Anton A W Mulder Department of Cardiology , St Antonius Hospital , PO Box 2500 , 3430 EM , Nieuwegein , The Netherlands Europace 14:818 - 25 .", "label": "", "metadata": {}, "score": "84.96573"}
{"text": "Anton A W Mulder Department of Cardiology , St Antonius Hospital , PO Box 2500 , 3430 EM Nieuwegein , The Netherlands Europace 14:1433 - 40 .", "label": "", "metadata": {}, "score": "85.00172"}
{"text": "Anton A W Mulder Department of Cardiology , St Antonius Hospital , PO Box 2500 , 3430 EM Nieuwegein , The Netherlands Europace 14:1433 - 40 .", "label": "", "metadata": {}, "score": "85.00172"}
{"text": "A prospective study from the Cancer and Leukemia Group B ( CALGB ) randomized women 70 years of age or older with tumors that were estrogen - receptor - positive and less than 2 cm in diameter to tamoxifen with or without radiotherapy .", "label": "", "metadata": {}, "score": "85.038536"}
{"text": "Finding no proposals for target volume delineation regarding flap reconstructions in an extensive literature search we have now started to fully include flap reconstructions in the CTV54 in case of synchronous ECE .", "label": "", "metadata": {}, "score": "85.393936"}
{"text": "However , the second one results from the addition of a polystyrene chain to tert - butyl nitroso that is in situ formed presumably by decomposition of the first macronitroxide type .", "label": "", "metadata": {}, "score": "85.54488"}
{"text": "CT - based treatment planning .Fields : included 2 cm margin on gross disease and included entire base of skull and sphenoid sinus , 2 cm posterior to mastoid process ; anteriorly included posterior 1/3 of maxillary sinus and nasal cavity .", "label": "", "metadata": {}, "score": "85.756485"}
{"text": "The control of the MMA polymerization relies on the strategy developed by Charleux et al .that consists of using a SG1-based alkoxyamine , i.e. the block - builder , in the presence of small amount of styrene .", "label": "", "metadata": {}, "score": "86.06037"}
{"text": "BT allowed by institutional preference ( ASTEC HDR 8/2 or LDR 15/1 , EN.5 per institution ) , BT given in 51 % of observation arm vs. 5 % of EBRT arm .", "label": "", "metadata": {}, "score": "86.312805"}
{"text": "PubMed View Article .Sher DJ , Thotakura V , Balboni TA , Norris CM Jr , Haddad RI , Posner MR , Lorch J , Goguen LA , Annino DJ , Tishler RB : Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity - modulated radiation therapy .", "label": "", "metadata": {}, "score": "86.46776"}
{"text": "Prince of Wales Hospital PWH-88 , Hong Kong ( 1988 - 1991 ) -- cisplatin , 5-FU .Randomized .82 patients .Arm 1 ) Neoadjuvant cisplatin 100 mg / m2 + 5-FU 1000 mg / m2 , 4 weeks later RT 66 Gy with lower neck to 58 Gy , then 4 cycles of adjuvant chemo vs. Arm 2 ) RT alone .", "label": "", "metadata": {}, "score": "87.01974"}
{"text": "Technical approaches of partial - breast irradiation include multicatheter interstitial brachytherapy , balloon catheter brachytherapy , three - dimensional conformal external - beam radiotherapy ( 3D - CRT ) and intraoperative radiotherapy ( IORT ) .", "label": "", "metadata": {}, "score": "88.04902"}
{"text": "Int J Radiat Oncol Biol Phys .2004 May 1;59(1):168 - 73 .Finland ( 1992 - 1996 ) -- pelvic EBRT vs. interdigitated chemo - RT .", "label": "", "metadata": {}, "score": "88.11029"}
{"text": "A bite block / tongue depressor was used to separate upper from lower jaw , all patients were additionally told to extend their ( remaining ) tongue to reach the backside of their lower jaw incisors and keep the tongue in this position during treatment if possible .", "label": "", "metadata": {}, "score": "88.2513"}
{"text": "Fields : superior border at L4/L5 , lateral borders 1 cm beyond pelvis , posterior border at posterior border of S3 , ant border at symphysis pubis .", "label": "", "metadata": {}, "score": "88.703224"}
{"text": "Keywords .Head and neck cancer IMRT Oral cavity Outcome Postoperative .Background .Treatment of locally advanced or high - risk oral cavity cancer ( OCC ) involves extensive surgical procedures , often combined with flap reconstruction , followed by postoperative radiotherapy ( RT ) with systemic therapy if certain risk factors are present .", "label": "", "metadata": {}, "score": "89.47247"}
{"text": "PubMed View Article .Guo H , Zhu H , Xi Y , Zhang B , Li L , Huang Y , Zhang J , Fu Z , Yang G , Yuan S , et al .", "label": "", "metadata": {}, "score": "89.511925"}
{"text": "PMMA microspheres were successfully prepared in supercritical carbon dioxide by controlled dispersion nitroxide mediated polymerization of methyl methacrylate using perfluorinated stabilizers that were generated \" in situ \" .", "label": "", "metadata": {}, "score": "89.58765"}
{"text": "Competing interest .The authors declare that there are no financial disclosures or conflict of interest that could be perceived as prejudicing the impartiality of the research reported .", "label": "", "metadata": {}, "score": "90.56065"}
{"text": "American journal of neuroradiology Volume : - ISSN : 1936 - 959X ISO Abbreviation : - Publication Date : 2011 Dec .Date Detail : .", "label": "", "metadata": {}, "score": "91.01193"}
{"text": "Accelerated partial - breast irradiation ( APBI ) is a collection of radiotherapy techniques that deliver higher daily doses of radiation to the surgical cavity with margin over a shorter time than WBI , reducing total treatment time from 6 - 6.5 weeks to 1 - 2 weeks .", "label": "", "metadata": {}, "score": "91.24535"}
{"text": "Introduction of APBI .In response , accelerated partial - breast irradiation ( APBI ) has been studied increasingly over the past 15 years as a viable alternative to WBI .", "label": "", "metadata": {}, "score": "91.87645"}
{"text": "European Organization for Research and Treatment of Cancer , National Cancer Institute of the United States , National Cancer Institute of Canada .J Natl Cancer Inst 2000 , 92 ( 3 ) : 205 - 216 .", "label": "", "metadata": {}, "score": "91.94959"}
{"text": "In a second step , nitroxide SG1 mediated dispersion polymerization of MMA was conducted at 70 \u00b0 C and 300 bar in the presence of 5 w% of SG1 terminated surfactant compared to the monomer .", "label": "", "metadata": {}, "score": "92.117096"}
{"text": "Finally , the effect of the addition of different salts on the micellar characteristic features is investigated .In this communication we report the first homopolymerization of a variety of methacrylates by an NMP process at moderate temperature ( 40 - 50 \u00b0 C ) , using an easily accessible and inexpensive nitroxide precursor .", "label": "", "metadata": {}, "score": "92.37456"}
{"text": "Results of Electron Spin Resonance ( ESR ) spectroscopy experiments combined with mass spectrometric studies support the proposed in situ NMP mechanism .The hindered structure of the nitroxides formed in situ is believed to be responsible for the efficiency of the process by allowing it to proceed at low temperature , therefore limiting the side reactions generally observed in NMP of methacrylates . in Journal of Polymer Science .", "label": "", "metadata": {}, "score": "92.805176"}
{"text": "2011Jan 19;103(2):92 - 104 .Epub 2011Jan 3 . )Retrospective .2 health systems : Monroe County , New York and Henry Ford Health System , Michigan .", "label": "", "metadata": {}, "score": "93.356094"}
{"text": "Department of Molecular Medicine & Biopharmaceutical Sciences , Graduate School of Convergence Science and Technology , Seoul National University .References .Nakeeb A , Tran KQ , Black MJ , Erickson BA , Ritch PS , Quebbeman EJ , Wilson SD , Demeure MJ , Rilling WS , Dua KS , et al .", "label": "", "metadata": {}, "score": "93.477234"}
{"text": "Declarations .Acknowledgements .Presented in part at the ECCO 15 and 34 th ESMO Multidisciplinary Congress , September 20 - 24 , 2009 , Berlin , Germany .", "label": "", "metadata": {}, "score": "94.13631"}
{"text": "Biliary tract cancers ( BTCs ) are rare , highly lethal carcinomas that develop from the epithelium of the gallbladder and bile duct .Because of the late clinical presentation of BTCs , only 10 % of patients are eligible for curative surgery [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "94.49016"}
{"text": "ESR studies combined with first principles calculations have evidenced that nitroxides observed during the prereaction in the presence of styrene and during the polymerization steps consist of a mixture of two macronitroxides .", "label": "", "metadata": {}, "score": "94.759766"}
{"text": "PubMed View Article .Pre - publication history .Copyright .\u00a9 Lee et al ; licensee BioMed Central Ltd. 2011 .Because Stage III - IV NPC has a fairly poor prognosis with RT alone , multiple efforts were made to add chemotherapy to the regimen .", "label": "", "metadata": {}, "score": "95.87431"}
{"text": "Contrast enhanced CT .All CT images were obtained using a multidetector - row computed tomography ( MDCT ) scanner ( Mx 8000 , Philips Healthcare ; or LightSpeed Ultra , GE Healthcare ; Sensation 16 , Simens Healthcare ) .", "label": "", "metadata": {}, "score": "96.03214"}
{"text": "P rior to the 1970s , the treatment of breast cancer was dominated by radical mastectomy or modified radical mastectomy of the affected breast .This consists of an en bloc removal of the breast , muscles of the chest wall , and contents of the axilla and was advocated as the most appropriate local therapy for women with early - stage breast cancers .", "label": "", "metadata": {}, "score": "96.09777"}
{"text": "Moreover , after depressurisation of the cell , PMMA was collected as a free flowing powder consisting of small sized microspheres .Controlled dispersion Nitroxide Mediated Polymerization ( NMP ) of methyl methacrylate ( MMA ) was successfully carried out for the first time in supercritical carbon dioxide ( scCO2 ) in the presence of CO2-philic perfluorinated surfactant that was generated \" in situ \" .", "label": "", "metadata": {}, "score": "97.144196"}
{"text": "The styrene polymerization initiated by benzoyl peroxide ( BPO ) in the presence of N - tert - butyl -- isopropylnitrone as nitroxide precursor is well - controlled provided that a prereaction between the nitrone and BPO is carried out in suitable conditions prior to polymerization at a higher temperature .", "label": "", "metadata": {}, "score": "97.16776"}
{"text": "PubMed View Article .Head Neck 2005 , 27 : 843 - 850 .PubMed View Article .Lancet Oncol 2011 , 12 : 127 - 136 .", "label": "", "metadata": {}, "score": "97.80677"}
{"text": "For geminally diphosphorylated linear nitroxide radicals , a marked line width alternation ( LWA ) can be observed .The conformational change is accompanied by the deformation of the CP2 bonding angle and the rate of exchange is slowed in pentane for which the solvent molecules can be trapped by the chelating phosphoryl groups .", "label": "", "metadata": {}, "score": "98.606606"}
{"text": "Departments of Neurosurgery and Radiology , Mayo Clinic , Rochester Minnesota ; and Department of Neurosurgery , Mayo Clinic , Jacksonville , Florida .Long - Term Follow - Up on Phase II Study of High - Dose Proton / Photon Radiotherapy for Spine Sarcomas .", "label": "", "metadata": {}, "score": "101.11133"}
{"text": "Localization and pattern of tumor recurrences in relation to the clinical target volumes .Outside FTB , not involving flap , extending to ipsilateral base of skull and Fossa infratemporalis , unifocal .", "label": "", "metadata": {}, "score": "102.86313"}
{"text": "Abigail Berman Milby , MD The Abramson Cancer Center of the University of Pennsylvania Last Modified : May 21 , 2012 .Presenting Author / Institution : Thomas DeLaney , MD / Massachusetts General Hospital .", "label": "", "metadata": {}, "score": "103.32918"}
{"text": "Department of Radiation Oncology and Division of Medical Radiation Physics , Bern University Hospital .SAKK Coordinating Center .Department of Otorhinolaryngology , University Hospital Bern .", "label": "", "metadata": {}, "score": "103.39461"}
{"text": "Different monomer to alkoxyamine molar ratios were investigated in order to target different molecular weights .Moreover , after depressurisation of the cell , PMMA was collected as a free flowing powder consisting of small sized microspheres .", "label": "", "metadata": {}, "score": "104.491745"}
{"text": "that consists of using a SG1-based alkoxyamine , i.e. the block - builder , in the presence of small amount of styrene .In a first step , CO2 soluble polyheptadecafluorodecylacrylate was prepared in scCO2 using block - builder as an alkoxyamine .", "label": "", "metadata": {}, "score": "105.401405"}
{"text": "Department of Internal Medicine , Seoul National University Hospital .Department of Radiation Oncology , Seoul National University Hospital .Department of Surgery , Seoul National University Hospital .", "label": "", "metadata": {}, "score": "107.65065"}
{"text": "Arm 1 ) RT alone vs. Arm 2 ) concurrent chemo - RT vs. Arm 3 ) RT + adjuvant chemo vs. Arm 4 ) concurrent chemo - RT + adjuvant RT .", "label": "", "metadata": {}, "score": "107.84973"}
{"text": "PubMed View Article .Copyright .\u00a9 Geretschl\u00e4ger et al . ; licensee BioMed Central Ltd. 2012 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "114.16044"}
{"text": "Medline Journal Info : .Nlm Unique ID : 8003708 Medline TA : AJNR Am J Neuroradiol Country : - .Other Details : .Languages : ENG Pagination : - Citation Subset : - .", "label": "", "metadata": {}, "score": "119.119194"}
